p130	B-protein
,	O
p107	B-protein
,	O
and	O
pRb	B-protein
are	O
differentially	O
regulated	O
in	O
proliferating	B-cell_type
cells	I-cell_type
and	O
during	O
cell	O
cycle	O
arrest	O
by	O
alpha-interferon	B-protein
.	O

We	O
have	O
determined	O
how	O
the	O
phosphorylation	O
of	O
the	O
retinoblastoma	B-protein
family	I-protein
(	O
pRb	B-protein
,	O
p107	B-protein
,	O
and	O
p130	B-protein
)	O
is	O
governed	O
in	O
individual	O
cell	O
cycle	O
phases	O
of	O
Daudi	B-cell_line
B-cells	I-cell_line
during	O
cell	O
cycle	O
exit	O
triggered	O
by	O
alpha-interferon	B-protein
(	O
alpha-IFN	B-protein
)	O
.	O

alpha-IFN	B-protein
causes	O
dephosphorylation	O
of	O
pRb	B-protein
and	O
loss	O
of	O
p130	B-protein
phosphorylated	I-protein
Form	I-protein
3	I-protein
.	O

However	O
,	O
the	O
change	O
in	O
p130	B-protein
phosphorylation	O
in	O
response	O
to	O
alpha-IFN	B-protein
occurs	O
before	O
dephosphorylation	O
of	O
pRb	B-protein
is	O
complete	O
because	O
loss	O
of	O
p130	B-protein
Form	I-protein
3	I-protein
occurs	O
throughout	O
the	O
cell	O
cycle	O
prior	O
to	O
complete	O
arrest	O
in	O
G1	O
,	O
whereas	O
pRb	B-protein
is	O
dephosphorylated	O
only	O
in	O
G1	O
.	O

In	O
contrast	O
,	O
p107	B-protein
is	O
dephosphorylated	O
and	O
is	O
then	O
depleted	O
from	O
cells	O
as	O
they	O
exit	O
the	O
cell	O
cycle	O
.	O

p130	B-protein
,	O
predominantly	O
in	O
Form	O
1	O
,	O
and	O
hypophosphorylated	B-protein
pRb	I-protein
bind	O
an	O
E2F	B-DNA
DNA	I-DNA
binding	I-DNA
site	I-DNA
;	O
p130	B-protein
complexes	O
E2F-4	B-protein
,	O
whereas	O
pRb	B-protein
binds	O
both	O
E2F-4	O
and	O
E2F-1	B-protein
.	O

The	O
phosphorylated	O
forms	O
of	O
E2F-4	B-protein
that	O
bind	O
to	O
the	O
E2F	B-DNA
DNA	I-DNA
site	I-DNA
are	O
different	O
from	O
hyperphosphorylated	O
E2F-4	B-protein
,	O
which	O
predominates	O
in	O
primary	B-cell_type
hemopoietic	I-cell_type
cells	I-cell_type
in	O
G0	O
.	O

We	O
conclude	O
that	O
although	O
cell	O
cycle	O
arrest	O
induced	O
by	O
alpha-IFN	B-protein
may	O
be	O
mediated	O
in	O
part	O
by	O
formation	O
of	O
a	O
complex	O
containing	O
p130	B-protein
and	O
E2F-4	B-protein
,	O
alpha-IFN	B-protein
does	O
not	O
induce	O
hyperphosphorylation	O
of	O
E2F-4	B-protein
,	O
which	O
characterizes	O
primary	B-cell_type
hemopoietic	I-cell_type
cells	I-cell_type
in	O
G0	O
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

273	NULL
,	NULL
No	NULL
.	NULL

37	NULL
,	NULL
Issue	NULL
of	NULL
September	NULL
11	NULL
,	NULL
pp	NULL
.	NULL

23659-23667	NULL
,	NULL
1998	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
p130	NULL
,	NULL
p107	NULL
,	NULL
and	NULL
pRb	NULL
Are	NULL
Differentially	NULL
Regulated	NULL
in	NULL
Proliferating	NULL
Cells	NULL
and	NULL
during	NULL
Cell	NULL
Cycle	NULL
Arrest	NULL
by	NULL
a-Interferon*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
December	NULL
18	NULL
,	NULL
1997	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
May	NULL
1	NULL
,	NULL
1998	NULL
)	NULL
Nicholas	NULL
S.	NULL
B.	NULL
Arnold	NULL
R.	NULL
Pizzey	NULL
,	NULL
Sanjay	NULL
Tiwari	NULL
,	NULL
Catherine	NULL
D.	NULL
Williams	NULL
,	NULL
and	NULL
Jiewu	NULL
Yang	NULL
From	NULL
the	NULL
Department	NULL
of	NULL
Haematology	NULL
,	NULL
University	NULL
College	NULL
London	NULL
Medical	NULL
School	NULL
,	NULL
98	NULL
Chenies	NULL
Mews	NULL
,	NULL
London	NULL
WCI1E	NULL
6HX	NULL
,	NULL
United	NULL
Kingdom	NULL
.	NULL

We	NULL
have	NULL
determined	NULL
how	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
retinoblastoma	NULL
family	NULL
(	NULL
pRb	NULL
,	NULL
p107	NULL
,	NULL
and	NULL
p130	NULL
)	NULL
is	NULL
governed	NULL
in	NULL
individual	NULL
cell	NULL
cycle	NULL
phases	NULL
of	NULL
Daudi	NULL
B-cells	NULL
during	NULL
cell	NULL
cycle	NULL
exit	NULL
triggered	NULL
by	NULL
a-interferon	NULL
(	NULL
«	NULL
-IFN	NULL
)	NULL
.	NULL

a	NULL
«	NULL
-IFN	NULL
causes	NULL
dephosphorylation	NULL
of	NULL
pRb	NULL
and	NULL
loss	NULL
of	NULL
p130	NULL
phosphorylated	NULL
Form	NULL
3	NULL
.	NULL

However	NULL
,	NULL
the	NULL
change	NULL
in	NULL
p130	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
«	NULL
-IFN	NULL
occurs	NULL
before	NULL
dephosphorylation	NULL
of	NULL
pRb	NULL
is	NULL
complete	NULL
because	NULL
loss	NULL
of	NULL
p130	NULL
Form	NULL
3	NULL
occurs	NULL
throughout	NULL
the	NULL
cell	NULL
cycle	NULL
prior	NULL
to	NULL
complete	NULL
arrest	NULL
in	NULL
G	NULL
,	NULL
,	NULL
whereas	NULL
pRb	NULL
is	NULL
dephosphorylated	NULL
only	NULL
in	NULL
G	NULL
,	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
p107	NULL
is	NULL
dephosphorylated	NULL
and	NULL
is	NULL
then	NULL
depleted	NULL
from	NULL
cells	NULL
as	NULL
they	NULL
exit	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

p130	NULL
,	NULL
predominantly	NULL
in	NULL
Form	NULL
1	NULL
,	NULL
and	NULL
hypophosphorylated	NULL
pRb	NULL
bind	NULL
an	NULL
E2F	NULL
DNA	NULL
binding	NULL
site	NULL
;	NULL
p130	NULL
complexes	NULL
E2F-4	NULL
,	NULL
whereas	NULL
pRb	NULL
binds	NULL
both	NULL
E2F-4	NULL
and	NULL
E2F-1	NULL
.	NULL

The	NULL
phosphorylated	NULL
forms	NULL
of	NULL
E2F-4	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
E2F	NULL
DNA	NULL
site	NULL
are	NULL
different	NULL
from	NULL
hyperphosphorylated	NULL
E2F-4	NULL
,	NULL
which	NULL
predominates	NULL
in	NULL
primary	NULL
hemopoietic	NULL
cells	NULL
in	NULL
G	NULL
,	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
although	NULL
cell	NULL
cycle	NULL
arrest	NULL
induced	NULL
by	NULL
a-IFN	NULL
may	NULL
be	NULL
mediated	NULL
in	NULL
part	NULL
by	NULL
formation	NULL
of	NULL
a	NULL
complex	NULL
containing	NULL
p130	NULL
and	NULL
E2F-4	NULL
,	NULL
«	NULL
-IFN	NULL
does	NULL
not	NULL
induce	NULL
hyperphosphorylation	NULL
of	NULL
E2F-4	NULL
,	NULL
which	NULL
characterizes	NULL
primary	NULL
hemopoietic	NULL
cells	NULL
in	NULL
G	NULL
,	NULL
,	NULL
.	NULL

The	NULL
protein	NULL
encoded	NULL
by	NULL
the	NULL
RB	NULL
gene	NULL
,	NULL
pRb	NULL
,	NULL
is	NULL
a	NULL
nuclear	NULL
phosphoprotein	NULL
that	NULL
is	NULL
involved	NULL
in	NULL
regulating	NULL
progression	NULL
through	NULL
G	NULL
,	NULL
into	NULL
S	NULL
phase	NULL
(	NULL
reviewed	NULL
in	NULL
Refs	NULL
.	NULL

1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

It	NULL
is	NULL
hypophosphorylated	NULL
in	NULL
G	NULL
,	NULL
and	NULL
is	NULL
phosphorylated	NULL
progressively	NULL
as	NULL
quiescent	NULL
cells	NULL
progress	NULL
through	NULL
G	NULL
,	NULL
,	NULL
reaching	NULL
a	NULL
hyperphosphorylated	NULL
form	NULL
at	NULL
the	NULL
G	NULL
;	NULL
-S	NULL
border	NULL
.	NULL

Hyperphosphorylation	NULL
is	NULL
thought	NULL
to	NULL
inactivate	NULL
pRb	NULL
,	NULL
allowing	NULL
cells	NULL
to	NULL
enter	NULL
S	NULL
phase	NULL
.	NULL

Microinjection	NULL
of	NULL
an	NULL
excess	NULL
of	NULL
purified	NULL
,	NULL
hypophosphorylated	NULL
pRb	NULL
up	NULL
to	NULL
mid	NULL
G	NULL
,	NULL
results	NULL
in	NULL
reversible	NULL
cell	NULL
cycle	NULL
arrest	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
pRb	NULL
may	NULL
only	NULL
be	NULL
required	NULL
up	NULL
to	NULL
a	NULL
point	NULL
some	NULL
time	NULL
in	NULL
mid-or	NULL
late	NULL
G	NULL
;	NULL
,	NULL
and	NULL
there	NULL
is	NULL
evidence	NULL
that	NULL
pRb	NULL
forms	NULL
part	NULL
of	NULL
the	NULL
mechanism	NULL
controlling	NULL
the	NULL
G	NULL
;	NULL
restriction	NULL
point	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

2	NULL
)	NULL
.	NULL

pRb	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
phosphorylated	NULL
by	NULL
a	NULL
succession	NULL
of	NULL
cyclin-dependent	NULL
kinases	NULL
(	NULL
cdks	NULL
)	NULL
,	NULL
'	NULL
which	NULL
are	NULL
activated	NULL
at	NULL
different	NULL
times	NULL
during	NULL
G	NULL
;	NULL
:	NULL
for	NULL
example	NULL
,	NULL
cdk6	NULL
and	NULL
edk4	NULL
are	NULL
activated	NULL
in	NULL
early	NULL
or	NULL
mid-G	NULL
,	NULL
,	NULL
followed	NULL
by	NULL
edk2	NULL
in	NULL
late	NULL
G	NULL
,	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

3	NULL
)	NULL
.	NULL

pRb	NULL
then	NULL
remains	NULL
hyperphosphorylated	NULL
throughout	NULL
the	NULL
rest	NULL
of	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Medical	NULL
Research	NULL
Council	NULL
(	NULL
to	NULL
J	NULL
.	NULL

Y	NULL
.	NULL
)	NULL

and	NULL
the	NULL
Kay	NULL
Kendall	NULL
Leukaemia	NULL
Trust	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

J	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
0171-209-6223	NULL
;	NULL
Fax	NULL
:	NULL
0171-209-6222	NULL
;	NULL
E-mail	NULL
:	NULL
nicholas.thomas	NULL
@	NULL
ucl.ac.uk	NULL
.	NULL

*The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
cdk	NULL
,	NULL
cyclin-dependent	NULL
kinase	NULL
;	NULL
IFN	NULL
,	NULL
interferon	NULL
;	NULL
FCS	NULL
,	NULL
fetal	NULL
calf	NULL
serum	NULL
;	NULL
PHA	NULL
,	NULL
phytohaemagglutinin	NULL
;	NULL
IL	NULL
,	NULL
in-terleukin	NULL
;	NULL
RA	NULL
,	NULL
retinoic	NULL
acid	NULL
;	NULL
PI	NULL
,	NULL
propidium	NULL
iodide	NULL
;	NULL
FITC	NULL
,	NULL
fluorescein	NULL
isothiocyanate	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
the	NULL
cell	NULL
cycle	NULL
and	NULL
is	NULL
dephosphorylated	NULL
to	NULL
a	NULL
hypophosphorylated	NULL
state	NULL
during	NULL
mitosis	NULL
,	NULL
possibly	NULL
by	NULL
a	NULL
type	NULL
1	NULL
serine-threonine	NULL
phosphatase	NULL
(	NULL
4	NULL
)	NULL
.	NULL

During	NULL
continuous	NULL
proliferation	NULL
,	NULL
cells	NULL
in	NULL
early	NULL
G	NULL
;	NULL
(	NULL
G	NULL
;	NULL
1	NULL
,	NULL
)	NULL
contain	NULL
partially	NULL
phosphorylated	NULL
pRb	NULL
(	NULL
5	NULL
)	NULL
,	NULL
which	NULL
becomes	NULL
hyperphosphorylated	NULL
during	NULL
late	NULL
G	NULL
,	NULL
(	NULL
G	NULL
;	NULL
1	NULL
$	NULL
)	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

The	NULL
hypophosphorylated	NULL
form	NULL
is	NULL
present	NULL
in	NULL
cells	NULL
that	NULL
are	NULL
quiescent	NULL
or	NULL
arrested	NULL
in	NULL
early	NULL
G	NULL
,	NULL
by	NULL
the	NULL
action	NULL
of	NULL
negative	NULL
growth	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
«	NULL
-interferon	NULL
(	NULL
a	NULL
«	NULL
-IFN	NULL
)	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
or	NULL
transforming	NULL
growth	NULL
factor-B	NULL
(	NULL
9-11	NULL
)	NULL
and	NULL
in	NULL
terminally	NULL
differentiated	NULL
cells	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

12	NULL
)	NULL
.	NULL

The	NULL
pRb	NULL
protein	NULL
shares	NULL
regions	NULL
of	NULL
homology	NULL
with	NULL
two	NULL
other	NULL
proteins	NULL
,	NULL
p107	NULL
and	NULL
p130	NULL
,	NULL
``	NULL
and	NULL
there	NULL
is	NULL
evidence	NULL
that	NULL
all	NULL
three	NULL
can	NULL
regulate	NULL
cell	NULL
proliferation	NULL
(	NULL
15-17	NULL
)	NULL
.	NULL

Like	NULL
pRb	NULL
,	NULL
they	NULL
are	NULL
phos-phoproteins	NULL
that	NULL
have	NULL
consensus	NULL
sites	NULL
for	NULL
phosphorylation	NULL
by	NULL
cdks	NULL
.	NULL

In	NULL
T98G	NULL
cells	NULL
that	NULL
are	NULL
entering	NULL
the	NULL
cell	NULL
cycle	NULL
for	NULL
the	NULL
first	NULL
time	NULL
from	NULL
G	NULL
,	NULL
,	NULL
p130	NULL
is	NULL
phosphorylated	NULL
to	NULL
Form	NULL
3	NULL
during	NULL
mid	NULL
G41	NULL
,	NULL
which	NULL
coincides	NULL
with	NULL
the	NULL
phosphorylation	NULL
of	NULL
pRb	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
cyclin	NULL
D1	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Exit	NULL
from	NULL
the	NULL
cell	NULL
cycle	NULL
caused	NULL
by	NULL
transforming	NULL
growth	NULL
factor-B	NULL
results	NULL
in	NULL
the	NULL
accumulation	NULL
of	NULL
p130	NULL
Form	NULL
1	NULL
,	NULL
and	NULL
exit	NULL
caused	NULL
by	NULL
serum	NULL
starvation	NULL
results	NULL
in	NULL
the	NULL
accumulation	NULL
of	NULL
Form	NULL
2	NULL
(	NULL
14	NULL
)	NULL
.	NULL

p107	NULL
is	NULL
not	NULL
phosphorylated	NULL
as	NULL
cells	NULL
enter	NULL
G	NULL
,	NULL
from	NULL
G	NULL
,	NULL
but	NULL
is	NULL
phosphorylated	NULL
from	NULL
S	NULL
phase	NULL
onward	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Cyclin	NULL
A-edk2	NULL
and	NULL
cyclin	NULL
E-edk2	NULL
associate	NULL
with	NULL
both	NULL
p107	NULL
and	NULL
p130	NULL
in	NULL
vitro	NULL
(	NULL
13	NULL
,	NULL
16	NULL
,	NULL
19-21	NULL
)	NULL
,	NULL
but	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
whether	NULL
cdk2	NULL
phosphorylates	NULL
either	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
there	NULL
is	NULL
evidence	NULL
that	NULL
p107	NULL
can	NULL
be	NULL
phosphorylated	NULL
in	NULL
cells	NULL
in	NULL
culture	NULL
by	NULL
cyclin	NULL
D1-edk4	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
hypophosphorylated	NULL
form	NULL
of	NULL
pRb	NULL
will	NULL
bind	NULL
transcription	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
E2F	NULL
,	NULL
which	NULL
regulate	NULL
genes	NULL
encoding	NULL
proteins	NULL
that	NULL
are	NULL
required	NULL
for	NULL
cell	NULL
cycle	NULL
progression	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

22	NULL
)	NULL
.	NULL

It	NULL
is	NULL
thought	NULL
that	NULL
this	NULL
is	NULL
also	NULL
how	NULL
p130	NULL
and	NULL
p107	NULL
function	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

23	NULL
)	NULL
.	NULL

The	NULL
E2F	NULL
transcription	NULL
factor	NULL
is	NULL
a	NULL
het-erodimer	NULL
of	NULL
an	NULL
E2F	NULL
protein	NULL
together	NULL
with	NULL
a	NULL
member	NULL
of	NULL
the	NULL
DP	NULL
family	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
major	NULL
E2F	NULL
complex	NULL
in	NULL
human	NULL
primary	NULL
,	NULL
CD34+	NULL
hemopoietic	NULL
progenitor	NULL
cells	NULL
(	NULL
24	NULL
)	NULL
and	NULL
in	NULL
quiescent	NULL
primary	NULL
T-cells	NULL
(	NULL
17	NULL
)	NULL
,	NULL
B-cells	NULL
,	NULL
and	NULL
monocytes	NULL
is	NULL
composed	NULL
of	NULL
E2F-4	NULL
,	NULL
together	NULL
with	NULL
DP-1	NULL
bound	NULL
to	NULL
p130	NULL
(	NULL
25	NULL
)	NULL
,	NULL
but	NULL
in	NULL
cycling	NULL
cells	NULL
,	NULL
E2F-4	NULL
binds	NULL
both	NULL
pRb	NULL
and	NULL
p107	NULL
(	NULL
26	NULL
)	NULL
or	NULL
p107	NULL
alone	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
p130-E2F-4-DP-1	NULL
complex	NULL
defines	NULL
G	NULL
,	NULL
(	NULL
27	NULL
)	NULL
,	NULL
because	NULL
this	NULL
complex	NULL
is	NULL
not	NULL
present	NULL
in	NULL
proliferating	NULL
cells	NULL
.	NULL

Different	NULL
members	NULL
of	NULL
the	NULL
pRb	NULL
family	NULL
have	NULL
some	NULL
specificity	NULL
for	NULL
different	NULL
E2Fs	NULL
:	NULL
E2F-1	NULL
,	NULL
-2	NULL
,	NULL
and	NULL
-3	NULL
bind	NULL
pRb	NULL
rather	NULL
than	NULL
p107	NULL
(	NULL
28	NULL
,	NULL
29	NULL
)	NULL
,	NULL
whereas	NULL
E2F-4	NULL
and	NULL
-5	NULL
bind	NULL
p130	NULL
and	NULL
p107	NULL
in	NULL
preference	NULL
to	NULL
pRb	NULL
(	NULL
17	NULL
,	NULL
30-32	NULL
)	NULL
.	NULL

The	NULL
functional	NULL
consequences	NULL
are	NULL
that	NULL
artificially	NULL
elevating	NULL
the	NULL
level	NULL
of	NULL
E2F-1	NULL
preferentially	NULL
overcomes	NULL
cell	NULL
cycle	NULL
arrest	NULL
by	NULL
pRb	NULL
,	NULL
and	NULL
E2F-4/DP-1	NULL
overcomes	NULL
arrest	NULL
caused	NULL
by	NULL
p130	NULL
(	NULL
30	NULL
,	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
expression	NULL
of	NULL
E2F-1	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
,	NULL
E2F-2	NULL
,	NULL
or	NULL
E2F-3	NULL
(	NULL
37	NULL
)	NULL
alone	NULL
or	NULL
*	NULL
The	NULL
nomenclature	NULL
adopted	NULL
for	NULL
different	NULL
phosphorylated	NULL
forms	NULL
of	NULL
p130	NULL
is	NULL
as	NULL
used	NULL
in	NULL
Refs	NULL
.	NULL

13	NULL
and	NULL
14	NULL
.	NULL

Forms	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
migrate	NULL
in	NULL
that	NULL
order	NULL
by	NULL
one-dimensional	NULL
SDS-PAGE	NULL
,	NULL
with	NULL
Form	NULL
3	NULL
migrating	NULL
slowest	NULL
.	NULL

28659	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
283660	NULL
E2F-4	NULL
in	NULL
combination	NULL
with	NULL
DP-1	NULL
(	NULL
30	NULL
,	NULL
34	NULL
)	NULL
causes	NULL
quiescent	NULL
cell	NULL
lines	NULL
to	NULL
progress	NULL
through	NULL
G	NULL
,	NULL
into	NULL
S	NULL
phase	NULL
.	NULL

Different	NULL
genes	NULL
are	NULL
induced	NULL
preferentially	NULL
by	NULL
different	NULL
E2Fs	NULL
(	NULL
37	NULL
)	NULL
;	NULL
for	NULL
example	NULL
,	NULL
the	NULL
genes	NULL
for	NULL
dihydrofolate	NULL
reductase	NULL
and	NULL
thymidine	NULL
kinase	NULL
by	NULL
E2F-2	NULL
,	NULL
for	NULL
cyclin	NULL
A	NULL
and	NULL
cdc2	NULL
by	NULL
both	NULL
E2F-1	NULL
and	NULL
-2	NULL
,	NULL
and	NULL
for	NULL
cdk2	NULL
by	NULL
E2F-3	NULL
.	NULL

Thus	NULL
individual	NULL
genes	NULL
with	NULL
specific	NULL
E2F	NULL
binding	NULL
sites	NULL
in	NULL
their	NULL
promoters	NULL
are	NULL
regulated	NULL
by	NULL
specific	NULL
E2Fs	NULL
,	NULL
and	NULL
so	NULL
regulation	NULL
of	NULL
individual	NULL
E2F-DP	NULL
combinations	NULL
by	NULL
different	NULL
pRb	NULL
family	NULL
members	NULL
provides	NULL
a	NULL
mechanism	NULL
for	NULL
turning	NULL
the	NULL
transcription	NULL
of	NULL
specific	NULL
genes	NULL
on	NULL
or	NULL
off	NULL
at	NULL
specific	NULL
times	NULL
during	NULL
entry	NULL
into	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

Indeed	NULL
,	NULL
pRb	NULL
,	NULL
p107	NULL
,	NULL
and	NULL
p130	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
individual	NULL
E2Fs	NULL
at	NULL
different	NULL
stages	NULL
during	NULL
entry	NULL
into	NULL
the	NULL
first	NULL
cell	NULL
cycle	NULL
(	NULL
Ref	NULL
.	NULL

26	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
,	NULL
and	NULL
so	NULL
transcription	NULL
controlled	NULL
by	NULL
specific	NULL
E2Fs	NULL
could	NULL
be	NULL
repressed	NULL
at	NULL
different	NULL
times	NULL
.	NULL

Such	NULL
coordinated	NULL
activation	NULL
of	NULL
transcription	NULL
is	NULL
required	NULL
for	NULL
cell	NULL
proliferation	NULL
because	NULL
transfection	NULL
of	NULL
either	NULL
pRb	NULL
,	NULL
p107	NULL
,	NULL
or	NULL
p130	NULL
will	NULL
prevent	NULL
progression	NULL
into	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
which	NULL
can	NULL
be	NULL
overcome	NULL
by	NULL
increased	NULL
expression	NULL
of	NULL
individual	NULL
E2Fs	NULL
(	NULL
17	NULL
,	NULL
38-40	NULL
)	NULL
.	NULL

However	NULL
,	NULL
suppression	NULL
of	NULL
cell	NULL
proliferation	NULL
by	NULL
p107	NULL
and	NULL
pRb	NULL
are	NULL
not	NULL
the	NULL
same	NULL
.	NULL

There	NULL
are	NULL
two	NULL
domains	NULL
in	NULL
p107	NULL
,	NULL
either	NULL
of	NULL
which	NULL
will	NULL
prevent	NULL
proliferation	NULL
(	NULL
41	NULL
)	NULL
:	NULL
one	NULL
domain	NULL
binds	NULL
E2F	NULL
,	NULL
and	NULL
in	NULL
this	NULL
respect	NULL
the	NULL
mechanism	NULL
of	NULL
growth	NULL
inhibition	NULL
may	NULL
be	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
pRb	NULL
;	NULL
the	NULL
second	NULL
growth-inhibitory	NULL
domain	NULL
of	NULL
p107	NULL
binds	NULL
cyclin	NULL
A	NULL
or	NULL
E-edk2	NULL
,	NULL
and	NULL
this	NULL
domain	NULL
does	NULL
not	NULL
have	NULL
a	NULL
counterpart	NULL
in	NULL
pRb	NULL
.	NULL

pRb	NULL
and	NULL
p107	NULL
may	NULL
also	NULL
differ	NULL
in	NULL
that	NULL
the	NULL
c-Myc	NULL
protein	NULL
,	NULL
which	NULL
is	NULL
important	NULL
in	NULL
driving	NULL
proliferation	NULL
,	NULL
is	NULL
inhibited	NULL
by	NULL
binding	NULL
to	NULL
p107	NULL
(	NULL
42	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
regulating	NULL
E2F	NULL
activity	NULL
,	NULL
pRb	NULL
also	NULL
regulates	NULL
the	NULL
activity	NULL
of	NULL
all	NULL
three	NULL
classes	NULL
of	NULL
RNA	NULL
polymerases	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

43	NULL
)	NULL
.	NULL

The	NULL
balance	NULL
between	NULL
particular	NULL
E2F	NULL
's	NULL
and	NULL
pRb	NULL
or	NULL
p130	NULL
is	NULL
clearly	NULL
important	NULL
in	NULL
determining	NULL
whether	NULL
a	NULL
cell	NULL
proliferates	NULL
,	NULL
remains	NULL
quiescent	NULL
,	NULL
or	NULL
is	NULL
driven	NULL
to	NULL
apoptosis	NULL
.	NULL

Cells	NULL
driven	NULL
by	NULL
E2F-1	NULL
enter	NULL
the	NULL
cell	NULL
cycle	NULL
and	NULL
then	NULL
die	NULL
later	NULL
by	NULL
apoptosis	NULL
(	NULL
44-46	NULL
)	NULL
.	NULL

E2F-2	NULL
and	NULL
E2F-3	NULL
also	NULL
cause	NULL
cells	NULL
to	NULL
enter	NULL
S	NULL
phase	NULL
,	NULL
but	NULL
neither	NULL
causes	NULL
apoptosis	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
E2F-driven	NULL
entry	NULL
into	NULL
S	NULL
phase	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
are	NULL
not	NULL
linked	NULL
;	NULL
rather	NULL
,	NULL
induction	NULL
of	NULL
apoptosis	NULL
is	NULL
unique	NULL
to	NULL
E2F-1	NULL
.	NULL

This	NULL
has	NULL
lead	NULL
to	NULL
the	NULL
suggestion	NULL
that	NULL
E2F-1	NULL
but	NULL
not	NULL
E2F-2	NULL
or	NULL
E2F-3	NULL
specifically	NULL
induces	NULL
genes	NULL
that	NULL
trigger	NULL
apoptosis	NULL
and	NULL
that	NULL
a	NULL
proliferating	NULL
cell	NULL
is	NULL
therefore	NULL
primed	NULL
for	NULL
apoptosis	NULL
unless	NULL
rescued	NULL
by	NULL
the	NULL
presence	NULL
of	NULL
anti-apoptotic	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
pRb	NULL
(	NULL
48	NULL
)	NULL
or	NULL
p53	NULL
(	NULL
87	NULL
)	NULL
.	NULL

From	NULL
what	NULL
has	NULL
been	NULL
described	NULL
above	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
regulation	NULL
of	NULL
cell	NULL
cycle	NULL
entry	NULL
is	NULL
complex	NULL
and	NULL
involves	NULL
a	NULL
coordinated	NULL
series	NULL
of	NULL
phosphorylations	NULL
of	NULL
key	NULL
cell	NULL
cycle	NULL
proteins	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
number	NULL
of	NULL
genes	NULL
.	NULL

Cell	NULL
cycle	NULL
exit	NULL
is	NULL
also	NULL
complex	NULL
,	NULL
and	NULL
this	NULL
is	NULL
illustrated	NULL
by	NULL
the	NULL
way	NULL
a-IFN	NULL
causes	NULL
cell	NULL
cycle	NULL
arrest	NULL
.	NULL

a-IFN	NULL
,	NULL
which	NULL
is	NULL
naturally	NULL
secreted	NULL
as	NULL
a	NULL
component	NULL
of	NULL
the	NULL
host	NULL
defense	NULL
mechanisms	NULL
of	NULL
the	NULL
body	NULL
,	NULL
has	NULL
marked	NULL
antiviral	NULL
proper-ties	NULL
,	NULL
but	NULL
«	NULL
-IFN	NULL
also	NULL
has	NULL
antiproliferative	NULL
effects	NULL
on	NULL
certain	NULL
cell	NULL
types	NULL
(	NULL
49	NULL
)	NULL
.	NULL

«	NULL
-IFN	NULL
was	NULL
thought	NULL
to	NULL
exert	NULL
its	NULL
antiproliferative	NULL
effect	NULL
in	NULL
part	NULL
via	NULL
the	NULL
pRb	NULL
pathway	NULL
(	NULL
5	NULL
,	NULL
7	NULL
,	NULL
50	NULL
,	NULL
51	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
cytostatic	NULL
effect	NULL
of	NULL
«	NULL
-IFN	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
a	NULL
more	NULL
complicated	NULL
series	NULL
of	NULL
mechanisms	NULL
that	NULL
lead	NULL
to	NULL
orderly	NULL
cell	NULL
cycle	NULL
arrest	NULL
rather	NULL
than	NULL
triggering	NULL
apoptosis	NULL
.	NULL

We	NULL
know	NULL
about	NULL
some	NULL
of	NULL
the	NULL
processes	NULL
involved	NULL
:	NULL
cdk	NULL
activity	NULL
is	NULL
decreased	NULL
(	NULL
51-55	NULL
)	NULL
,	NULL
which	NULL
may	NULL
be	NULL
due	NULL
in	NULL
part	NULL
to	NULL
a	NULL
decrease	NULL
in	NULL
edc25A	NULL
and	NULL
cyclins	NULL
D3	NULL
,	NULL
E	NULL
,	NULL
and	NULL
H	NULL
and	NULL
an	NULL
increase	NULL
in	NULL
p181N	NULL
*4C	NULL
in	NULL
Daudi	NULL
B-cells	NULL
(	NULL
54	NULL
,	NULL
56	NULL
)	NULL
and	NULL
induction	NULL
of	NULL
the	NULL
edk	NULL
inhibitors	NULL
p15	NULL
``	NULL
~**	NULL
``	NULL
,	NULL
p16	NULL
``	NULL
~**	NULL
,	NULL
p210®	NULL
``	NULL
,	NULL
and	NULL
p27	NULL
``	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
57-60	NULL
)	NULL
.	NULL

The	NULL
initial	NULL
phosphorylation	NULL
of	NULL
pRb	NULL
during	NULL
G	NULL
;	NULL
,	NULL
is	NULL
prevented	NULL
(	NULL
5	NULL
)	NULL
,	NULL
and	NULL
free	NULL
E2F	NULL
binding	NULL
to	NULL
DNA	NULL
is	NULL
reduced	NULL
(	NULL
8	NULL
,	NULL
62	NULL
)	NULL
.	NULL

The	NULL
latter	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
induction	NULL
by	NULL
«	NULL
-IFN	NULL
of	NULL
p202	NULL
(	NULL
63	NULL
)	NULL
,	NULL
a	NULL
protein	NULL
that	NULL
sequesters	NULL
EZF	NULL
in	NULL
a	NULL
form	NULL
that	NULL
does	NULL
not	NULL
bind	NULL
DNA	NULL
.	NULL

Other	NULL
transcription	NULL
factors	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
controlling	NULL
cell	NULL
proliferation	NULL
are	NULL
also	NULL
down-regu-	NULL
Cell	NULL
Cycle	NULL
Phosphorylation	NULL
of	NULL
the	NULL
pRb	NULL
Family	NULL
lated	NULL
.	NULL

For	NULL
example	NULL
,	NULL
the	NULL
activity	NULL
and	NULL
abundance	NULL
of	NULL
the	NULL
Oct-1	NULL
and	NULL
Oct-2	NULL
transcription	NULL
factors	NULL
is	NULL
decreased	NULL
(	NULL
64	NULL
)	NULL
,	NULL
and	NULL
«	NULL
-IFN	NULL
also	NULL
causes	NULL
the	NULL
depletion	NULL
of	NULL
the	NULL
c-MYC	NULL
protein	NULL
(	NULL
51	NULL
,	NULL
62	NULL
,	NULL
65	NULL
)	NULL
,	NULL
which	NULL
is	NULL
mediated	NULL
in	NULL
part	NULL
by	NULL
the	NULL
double-stranded	NULL
RNA-activated	NULL
ki-nase	NULL
,	NULL
PKR	NULL
(	NULL
66	NULL
)	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
expression	NULL
and	NULL
phosphorylation	NULL
of	NULL
pRb	NULL
,	NULL
p107	NULL
,	NULL
and	NULL
p130	NULL
during	NULL
the	NULL
transition	NULL
from	NULL
G	NULL
,	NULL
through	NULL
G	NULL
,	NULL
into	NULL
S	NULL
phase	NULL
has	NULL
been	NULL
studied	NULL
by	NULL
a	NULL
number	NULL
of	NULL
groups	NULL
.	NULL

However	NULL
,	NULL
the	NULL
processes	NULL
regulating	NULL
entry	NULL
into	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
G	NULL
,	NULL
-G	NULL
,	NULL
-8S	NULL
)	NULL
may	NULL
be	NULL
different	NULL
from	NULL
those	NULL
regulating	NULL
cell	NULL
cycle	NULL
progression	NULL
through	NULL
G	NULL
,	NULL
in	NULL
actively	NULL
cycling	NULL
cells	NULL
(	NULL
M-G	NULL
;	NULL
-8	NULL
)	NULL
(	NULL
67	NULL
)	NULL
and	NULL
are	NULL
poorly	NULL
understood	NULL
.	NULL

This	NULL
is	NULL
particularly	NULL
important	NULL
because	NULL
negative	NULL
growth	NULL
factors	NULL
,	NULL
such	NULL
as	NULL
a-IFN	NULL
,	NULL
exert	NULL
their	NULL
effects	NULL
on	NULL
actively	NULL
cycling	NULL
cells	NULL
.	NULL

We	NULL
showed	NULL
previously	NULL
that	NULL
a-IFN	NULL
causes	NULL
inhibition	NULL
of	NULL
pRb	NULL
phosphorylation	NULL
and	NULL
that	NULL
this	NULL
only	NULL
occurs	NULL
in	NULL
G	NULL
;	NULL
(	NULL
5	NULL
,	NULL
7	NULL
)	NULL
.	NULL

In	NULL
the	NULL
study	NULL
presented	NULL
here	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
p130	NULL
and	NULL
p107	NULL
are	NULL
regulated	NULL
by	NULL
a-IFN	NULL
and	NULL
whether	NULL
their	NULL
regulation	NULL
is	NULL
also	NULL
cell	NULL
cycle-dependent	NULL
.	NULL

Our	NULL
studies	NULL
show	NULL
that	NULL
regulation	NULL
of	NULL
the	NULL
phosphorylation	NULL
of	NULL
pRb	NULL
and	NULL
p107	NULL
is	NULL
different	NULL
from	NULL
that	NULL
of	NULL
p130	NULL
during	NULL
the	NULL
cell	NULL
cycle	NULL
of	NULL
actively	NULL
proliferating	NULL
cells	NULL
and	NULL
that	NULL
each	NULL
is	NULL
regulated	NULL
in	NULL
a	NULL
different	NULL
manner	NULL
by	NULL
«	NULL
-IFN	NULL
as	NULL
cells	NULL
exit	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents-Chemicals	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
unless	NULL
stated	NULL
otherwise	NULL
.	NULL

Cell	NULL
Culture-Cell	NULL
culture	NULL
and	NULL
T-cell	NULL
isolation	NULL
methods	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
5	NULL
,	NULL
7	NULL
,	NULL
52	NULL
,	NULL
68	NULL
)	NULL
,	NULL
with	NULL
additional	NULL
details	NULL
as	NULL
described	NULL
below	NULL
.	NULL

Primary	NULL
T-cells	NULL
were	NULL
isolated	NULL
from	NULL
the	NULL
peripheral	NULL
blood	NULL
of	NULL
normal	NULL
volunteers	NULL
and	NULL
were	NULL
at	NULL
least	NULL
80	NULL
%	NULL
pure	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
with	NULL
CD8	NULL
,	NULL
CD4	NULL
,	NULL
CD8	NULL
,	NULL
CD14	NULL
,	NULL
CD19	NULL
,	NULL
and	NULL
CD45	NULL
.	NULL

The	NULL
purified	NULL
T-cells	NULL
were	NULL
cultured	NULL
at	NULL
1	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
RPMI	NULL
medium/10	NULL
%	NULL
FCS	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
and	NULL
stimulated	NULL
with	NULL
1	NULL
ug/ml	NULL
phytohaemagglu-tinin	NULL
(	NULL
PHA	NULL
)	NULL
(	NULL
Glaxo-Wellcome	NULL
)	NULL
for	NULL
the	NULL
times	NULL
shown	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
PHA	NULL
for	NULL
60	NULL
h	NULL
,	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
(	NULL
Murex	NULL
)	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
20	NULL
ng/ml	NULL
,	NULL
and	NULL
culture	NULL
was	NULL
continued	NULL
for	NULL
5-7	NULL
days	NULL
.	NULL

IL-2	NULL
was	NULL
withdrawn	NULL
by	NULL
washing	NULL
the	NULL
cells	NULL
three	NULL
times	NULL
in	NULL
50	NULL
ml	NULL
of	NULL
prewarmed	NULL
RPMI	NULL
medium/10	NULL
%	NULL
FCS	NULL
per	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
re-seeded	NULL
in	NULL
the	NULL
same	NULL
medium	NULL
at	NULL
1	NULL
X	NULL
10°	NULL
cells/ml	NULL
.	NULL

Human	NULL
primary	NULL
,	NULL
CD34+	NULL
hemopoietic	NULL
progenitor	NULL
cells	NULL
were	NULL
isolated	NULL
and	NULL
cultured	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Cells	NULL
employed	NULL
in	NULL
this	NULL
study	NULL
were	NULL
surplus	NULL
to	NULL
patient	NULL
requirements	NULL
and	NULL
were	NULL
used	NULL
with	NULL
ethical	NULL
approval	NULL
.	NULL

Proliferating	NULL
Daudi	NULL
cells	NULL
(	NULL
obtained	NULL
from	NULL
Dr.	NULL
Ian	NULL
Kerr	NULL
,	NULL
Imperial	NULL
Cancer	NULL
Research	NULL
Fund	NULL
,	NULL
London	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
were	NULL
maintained	NULL
at	NULL
2-10	NULL
x	NULL
10°	NULL
cells/ml	NULL
in	NULL
RPMI	NULL
medium/10	NULL
%	NULL
FCS	NULL
and	NULL
were	NULL
split	NULL
to	NULL
2-4	NULL
X	NULL
10°	NULL
cells/ml	NULL
at	NULL
least	NULL
24	NULL
h	NULL
before	NULL
flow	NULL
cytometric	NULL
sorting	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
«	NULL
-IFN	NULL
(	NULL
Roferon	NULL
A	NULL
,	NULL
Hoffman-LaRoche	NULL
)	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
300	NULL
units/ml	NULL
.	NULL

HL60	NULL
cells	NULL
(	NULL
from	NULL
Dr.	NULL
Pamela	NULL
Roberts	NULL
,	NULL
Dept	NULL
.	NULL

of	NULL
Haematology	NULL
,	NULL
University	NULL
College	NULL
London	NULL
Medical	NULL
School	NULL
)	NULL
were	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
1	NULL
uM	NULL
all-frans-retinoic	NULL
acid	NULL
(	NULL
RA	NULL
)	NULL
and	NULL
their	NULL
differentiation	NULL
state	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
reduction	NULL
of	NULL
nitro	NULL
blue	NULL
tetrazolium	NULL
(	NULL
68	NULL
)	NULL
.	NULL

Flow	NULL
Cytometry-Two	NULL
color	NULL
flow	NULL
cytometry	NULL
of	NULL
DNA	NULL
(	NULL
stained	NULL
with	NULL
propidium	NULL
iodide	NULL
(	NULL
PT	NULL
)	NULL
)	NULL
and	NULL
total	NULL
cell	NULL
protein	NULL
(	NULL
stained	NULL
with	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
)	NULL
(	NULL
5	NULL
,	NULL
69	NULL
)	NULL
was	NULL
used	NULL
routinely	NULL
for	NULL
cell	NULL
cycle	NULL
analysis	NULL
.	NULL

Analysis	NULL
and	NULL
electronic	NULL
sorting	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
an	NULL
Epics-Elite	NULL
flow	NULL
cytometer	NULL
(	NULL
Coulter	NULL
Electronics	NULL
)	NULL
.	NULL

Doublets	NULL
of	NULL
cells	NULL
in	NULL
G	NULL
;	NULL
can	NULL
contaminate	NULL
the	NULL
G	NULL
,	NULL
-M	NULL
fraction	NULL
,	NULL
and	NULL
so	NULL
they	NULL
were	NULL
excluded	NULL
as	NULL
far	NULL
as	NULL
possible	NULL
by	NULL
only	NULL
including	NULL
cells	NULL
that	NULL
were	NULL
within	NULL
linear	NULL
gates	NULL
for	NULL
forward	NULL
scatter	NULL
versus	NULL
forward	NULL
scatter	NULL
peak	NULL
,	NULL
for	NULL
FITC	NULL
staining	NULL
versus	NULL
FITC	NULL
peak	NULL
,	NULL
and	NULL
also	NULL
for	NULL
PI	NULL
staining	NULL
versus	NULL
PI	NULL
peak	NULL
.	NULL

Populations	NULL
of	NULL
sorted	NULL
cells	NULL
were	NULL
centrifuged	NULL
at	NULL
400	NULL
x	NULL
g	NULL
for	NULL
7	NULL
min	NULL
and	NULL
resuspended	NULL
at	NULL
1	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
fresh	NULL
PIVFITC	NULL
stain	NULL
.	NULL

At	NULL
least	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
collected	NULL
in	NULL
each	NULL
sorted	NULL
fraction	NULL
,	NULL
and	NULL
the	NULL
yield	NULL
was	NULL
determined	NULL
by	NULL
manual	NULL
counting	NULL
using	NULL
an	NULL
improved	NULL
Neubauer	NULL
chamber	NULL
.	NULL

Approximately	NULL
5	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
re-analyzed	NULL
to	NULL
determine	NULL
their	NULL
purity	NULL
,	NULL
and	NULL
this	NULL
is	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
for	NULL
Figs	NULL
.	NULL

1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
4	NULL
.	NULL

In	NULL
each	NULL
case	NULL
,	NULL
cell	NULL
cycle	NULL
profiles	NULL
were	NULL
supplied	NULL
to	NULL
the	NULL
reviewers	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
remainder	NULL
were	NULL
centrifuged	NULL
at	NULL
400	NULL
X	NULL
g	NULL
for	NULL
7	NULL
min	NULL
in	NULL
microcentrifuge	NULL
tubes	NULL
,	NULL
resuspended	NULL
at	NULL
1	NULL
X	NULL
10	NULL
``	NULL
cells/ml	NULL
in	NULL
SDS-PAGE	NULL
sample	NULL
buffer	NULL
,	NULL
and	NULL
then	NULL
boiled	NULL
immediately	NULL
for	NULL
10	NULL
min	NULL
.	NULL

As	NULL
controls	NULL
,	NULL
fixed	NULL
and	NULL
PVFITC-stained	NULL
but	NULL
unsorted	NULL
cells	NULL
were	NULL
pelletted	NULL
and	NULL
boiled	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
.	NULL

The	NULL
SDS	NULL
sample	NULL
buffer	NULL
contained	NULL
protease	NULL
and	NULL
phosphatase	NULL
inhibitors	NULL
(	NULL
NaF	NULL
,	NULL
B-glycero-	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
Cell	NULL
Cycle	NULL
Phosphorylation	NULL
of	NULL
the	NULL
pRb	NULL
Family	NULL
phosphate	NULL
,	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
/14H,0	NULL
,	NULL
EGTA	NULL
,	NULL
phenylmethylsulfony	NULL
!	NULL

fluoride	NULL
,	NULL
Na	NULL
,	NULL
P,0	NULL
;	NULL
/10H,0	NULL
,	NULL
aprotinin	NULL
,	NULL
pepstatin	NULL
A	NULL
,	NULL
leupeptin	NULL
;	NULL
see	NULL
Ref	NULL
.	NULL

52	NULL
)	NULL
.	NULL

Either	NULL
1	NULL
or	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
were	NULL
loaded	NULL
in	NULL
each	NULL
lane	NULL
of	NULL
Western	NULL
blots	NULL
.	NULL

Immunoprecipitation	NULL
,	NULL
DNA	NULL
Binding	NULL
and	NULL
Western	NULL
Blotting-Immu-noprecipitations	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
1	NULL
X	NULL
10	NULL
``	NULL
Daudi	NULL
cells	NULL
lysed	NULL
in	NULL
800	NULL
ul	NULL
of	NULL
modified	NULL
immunoprecipitation	NULL
buffer	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
52	NULL
)	NULL
,	NULL
except	NULL
that	NULL
the	NULL
buffer	NULL
contained	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
rather	NULL
than	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
.	NULL

Solutions	NULL
were	NULL
kept	NULL
on	NULL
ice	NULL
,	NULL
and	NULL
all	NULL
manipulations	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
a	NULL
5	NULL
°C	NULL
cold-room	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
centrifuged	NULL
for	NULL
2	NULL
min	NULL
at	NULL
10,000	NULL
X	NULL
g	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
transferred	NULL
to	NULL
a	NULL
fresh	NULL
tube	NULL
,	NULL
and	NULL
the	NULL
nuclear	NULL
pellet	NULL
was	NULL
then	NULL
extracted	NULL
for	NULL
20	NULL
min	NULL
with	NULL
80	NULL
ul	NULL
of	NULL
the	NULL
same	NULL
buffer	NULL
containing	NULL
450	NULL
mM	NULL
NaCl	NULL
.	NULL

After	NULL
centrifugation	NULL
for	NULL
2	NULL
min	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
,	NULL
the	NULL
supernatants	NULL
were	NULL
pooled	NULL
and	NULL
preabsorbed	NULL
for	NULL
1-2	NULL
h	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
rabbit	NULL
IgG	NULL
(	NULL
DAKO	NULL
Ltd.	NULL
,	NULL
High	NULL
Wycombe	NULL
,	NULL
UK	NULL
)	NULL
and	NULL
20	NULL
ul	NULL
of	NULL
protein	NULL
A-agarose	NULL
(	NULL
Repligen	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
5	NULL
ug	NULL
of	NULL
anti-E2F-4	NULL
(	NULL
C20	NULL
)	NULL
antibody	NULL
and	NULL
then	NULL
with	NULL
protein	NULL
A-agarose	NULL
or	NULL
with	NULL
40	NULL
ug	NULL
of	NULL
anti-E2F-1	NULL
antibody	NULL
(	NULL
C20	NULL
)	NULL
coupled	NULL
to	NULL
Sepharose	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
)	NULL
.	NULL

One-third	NULL
of	NULL
each	NULL
immuno-precipitate	NULL
was	NULL
electrophoresed	NULL
per	NULL
gel	NULL
.	NULL

These	NULL
procedures	NULL
were	NULL
sufficient	NULL
to	NULL
extract	NULL
all	NULL
of	NULL
the	NULL
p130	NULL
,	NULL
pRb	NULL
,	NULL
and	NULL
p107	NULL
from	NULL
Daudi	NULL
cells	NULL
,	NULL
and	NULL
none	NULL
was	NULL
detected	NULL
when	NULL
SDS	NULL
lysates	NULL
of	NULL
the	NULL
residual	NULL
nuclear	NULL
pellets	NULL
were	NULL
subjected	NULL
to	NULL
Western	NULL
blotting	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Lysates	NULL
for	NULL
DNA	NULL
binding	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
for	NULL
immunoprecipitation	NULL
,	NULL
and	NULL
all	NULL
manipulations	NULL
were	NULL
at	NULL
5	NULL
°C	NULL
.	NULL

They	NULL
were	NULL
precleared	NULL
by	NULL
end-over-end	NULL
agitation	NULL
for	NULL
1	NULL
h	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
a	NULL
5'-biotinylated	NULL
,	NULL
mutant	NULL
form	NULL
of	NULL
the	NULL
E2F	NULL
double-stranded	NULL
DNA	NULL
binding	NULL
site	NULL
(	NULL
EZ2F	NULL
Y	NULL
``	NULL
:	NULL
biotin-5'-GATCTAGTTTTCGATATTAAATTTGA-3	NULL
'	NULL
)	NULL
and	NULL
20	NULL
ul	NULL
of	NULL
monomeric	NULL
avidin	NULL
coupled	NULL
to	NULL
a	NULL
methacrylate	NULL
matrix	NULL
(	NULL
Softlink	NULL
Avidin	NULL
,	NULL
Promega	NULL
)	NULL
.	NULL

After	NULL
centrifugation	NULL
at	NULL
10,000	NULL
%	NULL
g	NULL
for	NULL
10	NULL
s	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
E2F	NULL
DNA	NULL
binding	NULL
site	NULL
(	NULL
E2F	NULL
``	NULL
:	NULL
biotin-5'-GATCTAGTTTTCGCGCTTAAATTTGA-3	NULL
'	NULL
)	NULL
and	NULL
20	NULL
ul	NULL
of	NULL
avidin	NULL
beads	NULL
were	NULL
added	NULL
to	NULL
the	NULL
supernatant	NULL
,	NULL
which	NULL
was	NULL
mixed	NULL
on	NULL
a	NULL
wheel	NULL
for	NULL
1	NULL
h.	NULL
Both	NULL
sites	NULL
were	NULL
used	NULL
previously	NULL
for	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

The	NULL
beads	NULL
were	NULL
centrifuged	NULL
,	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
800	NULL
ul	NULL
of	NULL
low-salt	NULL
lysis	NULL
buffer	NULL
per	NULL
wash	NULL
,	NULL
and	NULL
the	NULL
proteins	NULL
bound	NULL
were	NULL
solubilized	NULL
by	NULL
boiling	NULL
for	NULL
10	NULL
min	NULL
in	NULL
30	NULL
ul	NULL
of	NULL
SDS	NULL
sample	NULL
buffer	NULL
prior	NULL
to	NULL
Western	NULL
blotting	NULL
.	NULL

We	NULL
note	NULL
that	NULL
the	NULL
biotinylated	NULL
DNA	NULL
can	NULL
not	NULL
be	NULL
released	NULL
from	NULL
the	NULL
beads	NULL
simply	NULL
by	NULL
incubating	NULL
with	NULL
excess	NULL
,	NULL
free	NULL
biotin	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Total	NULL
cell	NULL
lysates	NULL
for	NULL
Western	NULL
blotting	NULL
were	NULL
made	NULL
by	NULL
pelletting	NULL
cells	NULL
at	NULL
400	NULL
x	NULL
g	NULL
for	NULL
7	NULL
min	NULL
;	NULL
the	NULL
cells	NULL
were	NULL
then	NULL
boiled	NULL
for	NULL
10	NULL
min	NULL
in	NULL
2	NULL
%	NULL
SDS	NULL
sample	NULL
buffer	NULL
containing	NULL
protease	NULL
and	NULL
phosphatase	NULL
inhibitors	NULL
as	NULL
described	NULL
above	NULL
(	NULL
50	NULL
ul/l	NULL
X	NULL
10°	NULL
cells	NULL
)	NULL
.	NULL

The	NULL
percentages	NULL
of	NULL
polyacrylamide	NULL
gels	NULL
used	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
6	NULL
%	NULL
for	NULL
p180	NULL
,	NULL
pRb	NULL
,	NULL
and	NULL
p107	NULL
;	NULL
7.5	NULL
%	NULL
for	NULL
E2F-4	NULL
;	NULL
and	NULL
10	NULL
%	NULL
for	NULL
tubulin	NULL
.	NULL

All	NULL
gels	NULL
were	NULL
10-cm	NULL
mini	NULL
gels	NULL
(	NULL
Hoeffer	NULL
Mighty	NULL
Small	NULL
II	NULL
)	NULL
,	NULL
blotted	NULL
onto	NULL
Immobilon	NULL
P	NULL
(	NULL
Millipore	NULL
)	NULL
and	NULL
detected	NULL
by	NULL
ECL	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

The	NULL
antibodies	NULL
used	NULL
were	NULL
as	NULL
follows	NULL
:	NULL
anti-pRb	NULL
(	NULL
PMG	NULL
3-245	NULL
,	NULL
Pharmingen	NULL
)	NULL
;	NULL
anti-p180	NULL
(	NULL
C18	NULL
)	NULL
,	NULL
anti-p107	NULL
(	NULL
C20	NULL
)	NULL
,	NULL
and	NULL
anti-E2F-4	NULL
(	NULL
C20	NULL
)	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotech	NULL
,	NULL
Inc.	NULL
)	NULL
;	NULL
and	NULL
anti-tubulin	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
)	NULL
.	NULL

Whole	NULL
Cell	NULL
Extracts	NULL
and	NULL
Phosphatase	NULL
Treatment-Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
by	NULL
resuspending	NULL
2	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
in	NULL
100	NULL
ul	NULL
of	NULL
lysis	NULL
buffer	NULL
containing	NULL
20	NULL
mm	NULL
HEPES	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
450	NULL
mM	NULL
NaCl	NULL
,	NULL
25	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
glycerol	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
0.5	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
0.5	NULL
ug/ml	NULL
Sigma	NULL
protease	NULL
inhibitor	NULL
,	NULL
1.0	NULL
ug/ml	NULL
trypsin	NULL
inhibitor	NULL
,	NULL
0.5	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
40	NULL
pg/ml	NULL
bestatin	NULL
,	NULL
and	NULL
2	NULL
mM	NULL
diisofluorophosphate	NULL
.	NULL

This	NULL
was	NULL
subjected	NULL
to	NULL
three	NULL
freeze	NULL
(	NULL
dry	NULL
ice/etha-nol	NULL
)	NULL
-thaw	NULL
(	NULL
87	NULL
°C	NULL
)	NULL
cycles	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
then	NULL
centrifuged	NULL
at	NULL
10,000	NULL
g	NULL
,	NULL
4°C	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
removed	NULL
,	NULL
aliquoted	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-70	NULL
°C	NULL
.	NULL

Protein	NULL
concentration	NULL
in	NULL
the	NULL
extracts	NULL
was	NULL
measured	NULL
using	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
4	NULL
ug	NULL
of	NULL
protein	NULL
from	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
incubated	NULL
either	NULL
with	NULL
100	NULL
or	NULL
400	NULL
units	NULL
of	NULL
A	NULL
protein	NULL
phosphatase	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
in	NULL
25	NULL
pl	NULL
of	NULL
the	NULL
appropriate	NULL
buffer	NULL
with	NULL
or	NULL
without	NULL
50	NULL
mM	NULL
NaF	NULL
and	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
VO,14H,0	NULL
at	NULL
80	NULL
°C	NULL
for	NULL
the	NULL
times	NULL
shown	NULL
.	NULL

SDS	NULL
sample	NULL
buffer	NULL
was	NULL
then	NULL
added	NULL
to	NULL
the	NULL
samples	NULL
,	NULL
which	NULL
were	NULL
then	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
,	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
Western	NULL
blotted	NULL
.	NULL

RESULTS	NULL
p130	NULL
and	NULL
p107	NULL
in	NULL
Cells	NULL
Arrested	NULL
by	NULL
«	NULL
-IFN-The	NULL
pRb	NULL
protein	NULL
is	NULL
dephosphorylated	NULL
when	NULL
Daudi	NULL
cells	NULL
are	NULL
arrested	NULL
by	NULL
«	NULL
-IFN	NULL
(	NULL
7	NULL
)	NULL
,	NULL
and	NULL
this	NULL
causes	NULL
pRb	NULL
to	NULL
migrate	NULL
faster	NULL
on	NULL
SDS-gels	NULL
.	NULL

The	NULL
form	NULL
of	NULL
p130	NULL
that	NULL
migrates	NULL
slowest	NULL
(	NULL
Form	NULL
3	NULL
)	NULL
is	NULL
also	NULL
lost	NULL
in	NULL
cells	NULL
cultured	NULL
with	NULL
a-IFN	NULL
and	NULL
is	NULL
replaced	NULL
by	NULL
Forms	NULL
1	NULL
and	NULL
2	NULL
(	NULL
see	NULL
,	NULL
for	NULL
example	NULL
Fig	NULL
.	NULL

1A	NULL
and	NULL
B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
change	NULL
in	NULL
migration	NULL
of	NULL
p130	NULL
caused	NULL
by	NULL
a-IFN	NULL
can	NULL
be	NULL
accounted	NULL
for	NULL
by	NULL
phosphorylation	NULL
changes	NULL
,	NULL
we	NULL
incubated	NULL
23661	NULL
A	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
”	NULL
03	NULL
a	NULL
:	NULL
_	NULL
reas	NULL
0	NULL
To	NULL
|+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
4	NULL
+	NULL
|-	NULL
+	NULL
+	NULL
-	NULL
:	NULL
Ap'tase	NULL
lysate	NULL
[	NULL
f	NULL
4	NULL
4	NULL
-	NULL
.	NULL

4	NULL
-	NULL
-|-	NULL
O-	NULL
+	NULL
+	NULL
:	NULL
NaF+VOq	NULL
-	NULL
Hileo	NULL
0	NULL
2	NULL
5	NULL
10	NULL
20	NULL
60	NULL
|	NULL
-a-	NULL
so-	NULL
»	NULL
:	NULL
Int	NULL
;	NULL
ul	NULL
:	NULL
!	NULL

a	NULL
;	NULL
ion	NULL
min	NULL
B	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
80	NULL
9	NULL
10411213	NULL
a	NULL
sone	NULL
gout	NULL
gow	NULL
in	NULL
f-	NULL
3	NULL
a1*	NULL
4	NULL
``	NULL
``	NULL
®	NULL
~	NULL
-+I-+	NULL
G1A	NULL
st—+GuG2	NULL
o-IFN	NULL
-IFN	NULL
/M	NULL
Not	NULL
|	NULL
G1	NULL
/M	NULL
5	NULL
%	NULL
fixed	NULL
Fixed	NULL
T-	NULL
G1	NULL
<	NULL
--	NULL
-	NULL
®	NULL
!	NULL

9	NULL
Daudi	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

The	NULL
phosphorylation	NULL
state	NULL
of	NULL
p130	NULL
in	NULL
continuously	NULL
cycling	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
changes	NULL
in	NULL
p180	NULL
phosphorylation	NULL
alter	NULL
its	NULL
migration	NULL
in	NULL
SDS-PAGE	NULL
.	NULL

Daudi	NULL
whole	NULL
cell	NULL
extract	NULL
from	NULL
1	NULL
X	NULL
10°	NULL
cells	NULL
was	NULL
incubated	NULL
with	NULL
100	NULL
units	NULL
of	NULL
A-phosphatase	NULL
without	NULL
(	NULL
0-60	NULL
min	NULL
,	NULL
lanes	NULL
4-9	NULL
)	NULL
or	NULL
with	NULL
(	NULL
60	NULL
min	NULL
,	NULL
Zane	NULL
3	NULL
)	NULL
sodium	NULL
fluoride	NULL
and	NULL
sodium	NULL
orthovanadate	NULL
.	NULL

The	NULL
figure	NULL
shows	NULL
a	NULL
Western	NULL
blot	NULL
for	NULL
p180	NULL
and	NULL
the	NULL
positions	NULL
of	NULL
p180	NULL
Forms	NULL
0	NULL
,	NULL
1	NULL
,	NULL
2	NULL
,	NULL
and	NULL
3	NULL
are	NULL
shown	NULL
.	NULL

An	NULL
extract	NULL
was	NULL
also	NULL
incubated	NULL
for	NULL
60	NULL
min	NULL
with	NULL
a	NULL
higher	NULL
concentration	NULL
of	NULL
A-phosphatase	NULL
(	NULL
400	NULL
units	NULL
)	NULL
without	NULL
(	NULL
Fane	NULL
11	NULL
)	NULL
or	NULL
with	NULL
(	NULL
lane	NULL
12	NULL
)	NULL
sodium	NULL
fluoride	NULL
and	NULL
sodium	NULL
orthovanadate	NULL
.	NULL

Lanes	NULL
13	NULL
and	NULL
10	NULL
are	NULL
lysates	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
sodium	NULL
fluoride	NULL
and	NULL
sodium	NULL
orthovanadate	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
A-phosphatase	NULL
.	NULL

Proliferating	NULL
and	NULL
cells	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
with	NULL
a-IFN	NULL
and	NULL
lysed	NULL
directly	NULL
in	NULL
SDS	NULL
buffer	NULL
(	NULL
lanes	NULL
I	NULL
and	NULL
2	NULL
,	NULL
respectively	NULL
)	NULL
are	NULL
shown	NULL
for	NULL
comparison	NULL
.	NULL

Lanes	NULL
1-9	NULL
and	NULL
10-13	NULL
are	NULL
from	NULL
separate	NULL
gels	NULL
.	NULL

B	NULL
,	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
p130	NULL
in	NULL
proliferating	NULL
cells	NULL
.	NULL

Proliferating	NULL
Daudi	NULL
cells	NULL
were	NULL
fixed	NULL
and	NULL
stained	NULL
for	NULL
DNA	NULL
and	NULL
total	NULL
cell	NULL
protein	NULL
,	NULL
and	NULL
cells	NULL
in	NULL
G	NULL
;	NULL
,	NULL
and	NULL
Gp	NULL
,	NULL
S	NULL
,	NULL
and	NULL
G	NULL
,	NULL
-M	NULL
,	NULL
or	NULL
in	NULL
G	NULL
;	NULL
and	NULL
G	NULL
,	NULL
-M	NULL
were	NULL
isolated	NULL
by	NULL
flow	NULL
cytometry	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

The	NULL
purity	NULL
of	NULL
the	NULL
sorted	NULL
fractions	NULL
was	NULL
99.6	NULL
,	NULL
98.8	NULL
,	NULL
89	NULL
,	NULL
77	NULL
,	NULL
99.5	NULL
,	NULL
and	NULL
95	NULL
%	NULL
,	NULL
respectively	NULL
.	NULL

p180	NULL
in	NULL
G	NULL
,	NULL
,	NULL
,	NULL
G	NULL
;	NULL
»	NULL
,	NULL
8	NULL
,	NULL
and	NULL
G	NULL
,	NULL
-M	NULL
was	NULL
visualized	NULL
by	NULL
Western	NULL
blotting	NULL
(	NULL
Zanes	NULL
5-8	NULL
)	NULL
For	NULL
comparison	NULL
,	NULL
total	NULL
cell	NULL
lysates	NULL
of	NULL
quiescent	NULL
primary	NULL
T-cells	NULL
and	NULL
Daudi	NULL
cells	NULL
24	NULL
h	NULL
*	NULL
«	NULL
-IFN	NULL
run	NULL
on	NULL
the	NULL
same	NULL
gel	NULL
are	NULL
in	NULL
lanes	NULL
11	NULL
and	NULL
lanes	NULL
9	NULL
and	NULL
10	NULL
respectively	NULL
.	NULL

Lane	NULL
12	NULL
is	NULL
proliferating	NULL
Daudi	NULL
in	NULL
G	NULL
,	NULL
-M	NULL
(	NULL
95	NULL
%	NULL
G	NULL
,	NULL
-M	NULL
,	NULL
5	NULL
%	NULL
G	NULL
,	NULL
)	NULL
,	NULL
and	NULL
5	NULL
%	NULL
loading	NULL
of	NULL
cells	NULL
in	NULL
G	NULL
,	NULL
(	NULL
99.5	NULL
%	NULL
pure	NULL
)	NULL
is	NULL
shown	NULL
in	NULL
Zane	NULL
13	NULL
.	NULL

Daudi	NULL
cells	NULL
cultured	NULL
for	NULL
89	NULL
h	NULL
+	NULL
«	NULL
-IFN	NULL
and	NULL
lysed	NULL
directly	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
or	NULL
fixed	NULL
in	NULL
70	NULL
%	NULL
EtOH	NULL
and	NULL
stained	NULL
with	NULL
PI	NULL
and	NULL
FITC	NULL
prior	NULL
to	NULL
boiling	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

whole	NULL
cell	NULL
extracts	NULL
of	NULL
proliferating	NULL
Daudi	NULL
cells	NULL
in	NULL
vitro	NULL
with	NULL
or	NULL
without	NULL
the	NULL
dual-specificity	NULL
A	NULL
phosphatase	NULL
.	NULL

Phosphatase	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
caused	NULL
a	NULL
shift	NULL
from	NULL
p130	NULL
Form	NULL
3	NULL
to	NULL
a	NULL
species	NULL
that	NULL
comigrated	NULL
with	NULL
Forms	NULL
1	NULL
and	NULL
2	NULL
(	NULL
Zanes	NULL
4-9	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
faster	NULL
migrating	NULL
form	NULL
(	NULL
Form	NULL
O0	NULL
)	NULL
when	NULL
a	NULL
higher	NULL
concentration	NULL
of	NULL
A-phosphatase	NULL
was	NULL
used	NULL
(	NULL
Zane	NULL
11	NULL
)	NULL
.	NULL

The	NULL
shift	NULL
was	NULL
inhibited	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
phosphoatase	NULL
inhibitors	NULL
(	NULL
Zanes	NULL
3	NULL
and	NULL
12	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
changes	NULL
in	NULL
the	NULL
migration	NULL
of	NULL
p130	NULL
in	NULL
response	NULL
to	NULL
«	NULL
-IFN	NULL
are	NULL
consistent	NULL
with	NULL
its	NULL
dephosphorylation	NULL
.	NULL

We	NULL
showed	NULL
previously	NULL
that	NULL
dephosphorylation	NULL
of	NULL
pRb	NULL
occurs	NULL
exclusively	NULL
in	NULL
G	NULL
,	NULL
even	NULL
after	NULL
culturing	NULL
Daudi	NULL
cells	NULL
for	NULL
prolonged	NULL
periods	NULL
with	NULL
a-IFN	NULL
(	NULL
5	NULL
)	NULL
.	NULL

We	NULL
wished	NULL
to	NULL
determine	NULL
whether	NULL
dephosphorylation	NULL
of	NULL
p130	NULL
occurs	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
,	NULL
but	NULL
before	NULL
being	NULL
able	NULL
to	NULL
do	NULL
so	NULL
,	NULL
we	NULL
first	NULL
had	NULL
to	NULL
determine	NULL
how	NULL
its	NULL
phosphorylation	NULL
is	NULL
regulated	NULL
during	NULL
the	NULL
cell	NULL
cycle	NULL
of	NULL
continuously	NULL
cycling	NULL
cells	NULL
.	NULL

Proliferating	NULL
Daudi	NULL
cells	NULL
in	NULL
different	NULL
cell	NULL
cycle	NULL
phases	NULL
were	NULL
isolated	NULL
by	NULL
flow	NULL
cytometric	NULL
sorting	NULL
,	NULL
and	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
p130	NULL
was	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

The	NULL
sorting	NULL
protocol	NULL
involves	NULL
fixing	NULL
the	NULL
cells	NULL
in	NULL
70	NULL
%	NULL
ethanol	NULL
at	NULL
-20	NULL
°C	NULL
prior	NULL
to	NULL
staining	NULL
for	NULL
flow	NULL
cytometry	NULL
,	NULL
but	NULL
this	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
migration	NULL
of	NULL
p130	NULL
in	NULL
SDS	NULL
gels	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
(	NULL
not	NULL
fixed	NULL
)	NULL
with	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
(	NULL
fixed	NULL
)	NULL
)	NULL
.	NULL

p130	NULL
was	NULL
present	NULL
predominantly	NULL
as	NULL
phosphorylated	NULL
Form	NULL
3	NULL
in	NULL
each	NULL
cell	NULL
cycle	NULL
phase	NULL
isolated	NULL
from	NULL
G	NULL
,	NULL
,	NULL
through	NULL
to	NULL
G	NULL
,	NULL
-M	NULL
(	NULL
Fig	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
23662	NULL
Cell	NULL
Cycle	NULL
Phosphorylation	NULL
of	NULL
the	NULL
pRb	NULL
Family	NULL
B	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
@	NULL
m-	NULL
os	NULL
is	NULL
«	NULL
a	NULL
B	NULL
%	NULL
~	NULL
m	NULL
|-	NULL
:	NULL
2130	NULL
t=0	NULL
t=2h	NULL
t=6h	NULL
t=12h	NULL
&	NULL
[	NULL
|	NULL
||	NULL
1	NULL
||	NULL
Sef	NULL
|	NULL
|	NULL
femal	NULL
)	NULL
|	NULL
|	NULL
]	NULL
‘	NULL
é	NULL
+4	NULL
=i	NULL
we-	NULL
=B	NULL
>	NULL
-	NULL
|	NULL
|	NULL
a	NULL
.	NULL

40°	NULL
ii	NULL
1	NULL
f	NULL
Scof|	NULL
.	NULL

/P	NULL
1	NULL
t	NULL
/	NULL
[	NULL
§	NULL
i-	NULL
Lo	NULL
L_	NULL
_	NULL
L2	NULL
4A	NULL
Me	NULL
DNA	NULL
a=	NULL
GO=98	NULL
%	NULL
;	NULL
G1=2	NULL
%	NULL
.	NULL

GO=98	NULL
%	NULL
;	NULL
G1=2	NULL
%	NULL
-	NULL
GO=95	NULL
%	NULL
;	NULL
G1=§	NULL
%	NULL
.	NULL

GO=85	NULL
%	NULL
;	NULL
G1=15	NULL
%	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
t=14h	NULL
t=16h	NULL
t=18h	NULL
t=20h	NULL
``	NULL
ra	NULL
-l	NULL
4	NULL
-|	NULL
4	NULL
6	NULL
)	NULL
,	NULL
,	NULL
-	NULL
pRb	NULL
-	NULL
s-	NULL
as	NULL
#	NULL
I	NULL
&	NULL
i	NULL
=	NULL
33	NULL
S5	NULL
)	NULL
(	NULL
©	NULL
t=0	NULL
2	NULL
6	NULL
12	NULL
14	NULL
16	NULL
18	NULL
200	NULL
-	NULL
+oIFN	NULL
--	NULL
T-cells	NULL
--	NULL
»	NULL
Daudi	NULL
+	NULL
PHA	NULL
GO282	NULL
%	NULL
;	NULL
G1=18	NULL
%	NULL
.	NULL

GO=74	NULL
%	NULL
;	NULL
G1=26	NULL
%	NULL
-	NULL
G0=87	NULL
%	NULL
;	NULL
G1=30	NULL
%	NULL
-	NULL
G0=49	NULL
%	NULL
;	NULL
G1=51	NULL
%	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Phosphorylation	NULL
of	NULL
p130	NULL
and	NULL
pRb	NULL
in	NULL
primary	NULL
T-cells	NULL
during	NULL
G	NULL
,	NULL
-	NULL
>	NULL
G	NULL
,	NULL
.	NULL

A	NULL
,	NULL
two	NULL
color	NULL
flow	NULL
cytometry	NULL
.	NULL

Human	NULL
primary	NULL
T-cells	NULL
were	NULL
stimulated	NULL
with	NULL
PHA	NULL
for	NULL
the	NULL
times	NULL
shown	NULL
,	NULL
fixed	NULL
,	NULL
and	NULL
stained	NULL
for	NULL
DNA	NULL
(	NULL
PT	NULL
)	NULL
and	NULL
total	NULL
cell	NULL
protein	NULL
(	NULL
FITC	NULL
)	NULL
The	NULL
flow	NULL
cytometry	NULL
profiles	NULL
are	NULL
shown	NULL
,	NULL
and	NULL
the	NULL
percentages	NULL
of	NULL
cells	NULL
in	NULL
G	NULL
,	NULL
,	NULL
and	NULL
G	NULL
,	NULL
are	NULL
indicated	NULL
below	NULL
each	NULL
panel	NULL
.	NULL

B	NULL
,	NULL
Western	NULL
blots	NULL
of	NULL
p130	NULL
and	NULL
pRb	NULL
.	NULL

The	NULL
phosphorylation	NULL
states	NULL
of	NULL
pRb	NULL
and	NULL
p180	NULL
in	NULL
the	NULL
primary	NULL
T-cells	NULL
stimulated	NULL
for	NULL
0-20	NULL
h	NULL
(	NULL
Zanes	NULL
1-8	NULL
and	NULL
11-18	NULL
)	NULL
were	NULL
determined	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

Daudi	NULL
cells	NULL
cultured	NULL
without	NULL
(	NULL
Janes	NULL
9	NULL
and	NULL
10	NULL
)	NULL
or	NULL
with	NULL
(	NULL
lanes	NULL
19	NULL
and	NULL
20	NULL
)	NULL
a-IFN	NULL
for	NULL
48	NULL
h	NULL
are	NULL
shown	NULL
.	NULL

pRb	NULL
(	NULL
p	NULL
)	NULL
and	NULL
pRb	NULL
indicate	NULL
hyper-	NULL
and	NULL
hypophosphorylated	NULL
forms	NULL
of	NULL
pRb	NULL
,	NULL
respectively	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
5-8	NULL
)	NULL
,	NULL
which	NULL
indicates	NULL
that	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
p130	NULL
does	NULL
not	NULL
change	NULL
substantially	NULL
as	NULL
continuously	NULL
cycling	NULL
cells	NULL
progress	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

The	NULL
migration	NULL
of	NULL
p130	NULL
Forms	NULL
1	NULL
and	NULL
2	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
the	NULL
sample	NULL
of	NULL
quiescent	NULL
primary	NULL
T-cells	NULL
run	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
11	NULL
.	NULL

It	NULL
was	NULL
difficult	NULL
to	NULL
isolate	NULL
pure	NULL
populations	NULL
of	NULL
cells	NULL
in	NULL
G	NULL
,	NULL
-M	NULL
that	NULL
were	NULL
free	NULL
of	NULL
doublets	NULL
of	NULL
cells	NULL
in	NULL
G	NULL
;	NULL
,	NULL
and	NULL
in	NULL
most	NULL
cases	NULL
,	NULL
sort	NULL
purities	NULL
were	NULL
similar	NULL
to	NULL
the	NULL
experiment	NULL
shown	NULL
.	NULL

Because	NULL
it	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
p130	NULL
is	NULL
depleted	NULL
from	NULL
cells	NULL
in	NULL
G	NULL
,	NULL
-M	NULL
(	NULL
14	NULL
)	NULL
,	NULL
the	NULL
signal	NULL
we	NULL
observed	NULL
from	NULL
these	NULL
cells	NULL
could	NULL
have	NULL
been	NULL
contributed	NULL
solely	NULL
by	NULL
the	NULL
G	NULL
,	NULL
cell	NULL
contaminants	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
this	NULL
is	NULL
the	NULL
case	NULL
,	NULL
we	NULL
isolated	NULL
a	NULL
small	NULL
number	NULL
of	NULL
~95	NULL
%	NULL
pure	NULL
cells	NULL
in	NULL
G	NULL
,	NULL
-M	NULL
and	NULL
compared	NULL
the	NULL
p130	NULL
signal	NULL
with	NULL
that	NULL
obtained	NULL
from	NULL
the	NULL
number	NULL
of	NULL
G	NULL
cells	NULL
(	NULL
>	NULL
99	NULL
%	NULL
pure	NULL
)	NULL
that	NULL
contaminate	NULL
the	NULL
G	NULL
,	NULL
-M	NULL
preparation	NULL
(	NULL
i.e	NULL
.	NULL

5	NULL
%	NULL
of	NULL
sorted	NULL
cells	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
12	NULL
and	NULL
13	NULL
,	NULL
the	NULL
contaminating	NULL
G	NULL
,	NULL
cells	NULL
did	NULL
not	NULL
account	NULL
for	NULL
the	NULL
p130	NULL
signal	NULL
from	NULL
cells	NULL
in	NULL
G	NULL
,	NULL
-M	NULL
.	NULL

The	NULL
total	NULL
cellular	NULL
protein	NULL
content	NULL
increased	NULL
as	NULL
cells	NULL
progressed	NULL
from	NULL
G	NULL
;	NULL
,	NULL
through	NULL
to	NULL
G	NULL
,	NULL
-M	NULL
,	NULL
and	NULL
the	NULL
relative	NULL
ratio	NULL
for	NULL
Daudi	NULL
cells	NULL
was	NULL
approximately	NULL
as	NULL
follows	NULL
:	NULL
G	NULL
;	NULL
a	NULL
=	NULL
1	NULL
;	NULL
Gp	NULL
=	NULL
1.5	NULL
;	NULL
8	NULL
=	NULL
1.7	NULL
;	NULL
G	NULL
,	NULL
-M	NULL
=	NULL
2.2	NULL
.	NULL

Because	NULL
the	NULL
same	NULL
number	NULL
of	NULL
cells	NULL
were	NULL
loaded	NULL
on	NULL
each	NULL
lane	NULL
of	NULL
the	NULL
gels	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
5-8	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
p130	NULL
decreases	NULL
during	NULL
the	NULL
cell	NULL
cycle	NULL
relative	NULL
to	NULL
total	NULL
cell	NULL
protein	NULL
,	NULL
but	NULL
p130	NULL
is	NULL
not	NULL
depleted	NULL
completely	NULL
from	NULL
Daudi	NULL
cells	NULL
in	NULL
S	NULL
and	NULL
G	NULL
,	NULL
-M.	NULL
Phosphorylation	NULL
of	NULL
p130	NULL
and	NULL
pRb	NULL
during	NULL
Cell	NULL
Cycle	NULL
Entry	NULL
from	NULL
G	NULL
,	NULL
-p130	NULL
is	NULL
present	NULL
in	NULL
Forms	NULL
1	NULL
and	NULL
2	NULL
when	NULL
Daudi	NULL
cells	NULL
cultured	NULL
with	NULL
0.5	NULL
%	NULL
FCS	NULL
exit	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

The	NULL
two-color	NULL
cell	NULL
cycle	NULL
profile	NULL
of	NULL
these	NULL
cells	NULL
coincides	NULL
with	NULL
proliferating	NULL
cells	NULL
in	NULL
G	NULL
;	NULL
,	NULL
and	NULL
so	NULL
they	NULL
can	NULL
not	NULL
be	NULL
used	NULL
to	NULL
determine	NULL
when	NULL
p130	NULL
is	NULL
phosphorylated	NULL
to	NULL
Form	NULL
3	NULL
as	NULL
cells	NULL
enter	NULL
the	NULL
cell	NULL
cycle	NULL
from	NULL
G	NULL
,	NULL
.	NULL

Human	NULL
primary	NULL
T-cells	NULL
isolated	NULL
from	NULL
peripheral	NULL
blood	NULL
are	NULL
in	NULL
G	NULL
,	NULL
;	NULL
they	NULL
are	NULL
small	NULL
cells	NULL
with	NULL
2	NULL
N	NULL
DNA	NULL
content	NULL
and	NULL
low	NULL
protein	NULL
and	NULL
RNA	NULL
content	NULL
,	NULL
and	NULL
both	NULL
protein	NULL
and	NULL
RNA	NULL
content	NULL
increase	NULL
as	NULL
cells	NULL
enter	NULL
G	NULL
;	NULL
,	NULL
from	NULL
Go	NULL
(	NULL
see	NULL
Ref	NULL
.	NULL

5	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
used	NULL
these	NULL
cells	NULL
to	NULL
determine	NULL
when	NULL
p130	NULL
and	NULL
pRb	NULL
are	NULL
phosphorylated	NULL
as	NULL
cells	NULL
enter	NULL
G	NULL
,	NULL
from	NULL
G	NULL
,	NULL
.	NULL

Two	NULL
color	NULL
flow	NULL
cytometry	NULL
showed	NULL
that	NULL
T-cells	NULL
enter	NULL
G	NULL
,	NULL
,	NULL
at	NULL
about	NULL
12-14	NULL
h	NULL
after	NULL
stimulation	NULL
with	NULL
PHA	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
,	NULL
at	NULL
which	NULL
time	NULL
p130	NULL
Form	NULL
3	NULL
was	NULL
detectable	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Hyperphosphorylated	NULL
pRb	NULL
was	NULL
also	NULL
detectable	NULL
by	NULL
Western	NULL
blotting	NULL
at	NULL
the	NULL
same	NULL
time	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
14	NULL
and	NULL
15	NULL
)	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
previously	NULL
that	NULL
p130	NULL
is	NULL
also	NULL
phosphorylated	NULL
to	NULL
Form	NULL
3	NULL
from	NULL
Forms	NULL
1	NULL
and	NULL
2	NULL
as	NULL
human	NULL
primary	NULL
CD34+	NULL
hemopoietic	NULL
progenitor	NULL
cells	NULL
enter	NULL
G	NULL
,	NULL
,	NULL
from	NULL
G	NULL
;	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
data	NULL
with	NULL
two	NULL
primary	NULL
cell	NULL
types	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
whereby	NULL
p130	NULL
becomes	NULL
inactivated	NULL
at	NULL
or	NULL
before	NULL
the	NULL
G	NULL
,	NULL
to	NULL
G	NULL
;	NULL
,	NULL
transition	NULL
and	NULL
thereafter	NULL
remains	NULL
inactive	NULL
throughout	NULL
the	NULL
cell	NULL
cycle	NULL
of	NULL
actively	NULL
cycling	NULL
cells	NULL
.	NULL

Regulation	NULL
of	NULL
p130	NULL
and	NULL
pRb	NULL
by	NULL
«	NULL
-IFN-Next	NULL
,	NULL
we	NULL
investigated	NULL
how	NULL
p130	NULL
is	NULL
regulated	NULL
during	NULL
cell	NULL
cycle	NULL
arrest	NULL
caused	NULL
by	NULL
a	NULL
«	NULL
-IFN	NULL
.	NULL

At	NULL
24	NULL
h	NULL
after	NULL
the	NULL
addition	NULL
of	NULL
«	NULL
-IFN	NULL
,	NULL
p130	NULL
Form	NULL
3	NULL
is	NULL
partially	NULL
depleted	NULL
and	NULL
Forms	NULL
1	NULL
and	NULL
2	NULL
are	NULL
detectable	NULL
.	NULL

Loss	NULL
of	NULL
Form	NULL
3	NULL
occurs	NULL
only	NULL
in	NULL
G	NULL
;	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
and	NULL
not	NULL
in	NULL
S	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
G	NULL
,	NULL
-M	NULL
phases	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

This	NULL
is	NULL
similar	NULL
to	NULL
pRb	NULL
,	NULL
which	NULL
we	NULL
showed	NULL
previously	NULL
is	NULL
only	NULL
dephosphorylated	NULL
to	NULL
a	NULL
hypophosphorylated	NULL
form	NULL
in	NULL
G	NULL
,	NULL
(	NULL
5	NULL
)	NULL
.	NULL

After	NULL
36-48	NULL
h	NULL
with	NULL
«	NULL
-IFN	NULL
,	NULL
p130	NULL
Form	NULL
3	NULL
is	NULL
replaced	NULL
completely	NULL
by	NULL
Forms	NULL
1	NULL
and	NULL
2	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
this	NULL
occurs	NULL
at	NULL
a	NULL
time	NULL
when	NULL
hyperphosphorylated	NULL
pRb	NULL
is	NULL
still	NULL
present	NULL
(	NULL
compare	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
;	NULL
see	NULL
also	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
lanes	NULL
10	NULL
and	NULL
20	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
p130	NULL
Form	NULL
3	NULL
is	NULL
depleted	NULL
in	NULL
phases	NULL
other	NULL
than	NULL
G	NULL
;	NULL
,	NULL
we	NULL
sorted	NULL
Daudi	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
cultured	NULL
with	NULL
«	NULL
-IFN	NULL
for	NULL
about	NULL
40	NULL
h.	NULL
Two	NULL
color	NULL
flow	NULL
cytometry	NULL
of	NULL
DNA	NULL
versus	NULL
protein	NULL
content	NULL
showed	NULL
that	NULL
at	NULL
this	NULL
time	NULL
cell	NULL
cycle	NULL
arrest	NULL
in	NULL
G	NULL
,	NULL
was	NULL
not	NULL
yet	NULL
complete	NULL
and	NULL
that	NULL
there	NULL
was	NULL
still	NULL
a	NULL
significant	NULL
number	NULL
of	NULL
cells	NULL
in	NULL
mid	NULL
to	NULL
late	NULL
S	NULL
and	NULL
G	NULL
;	NULL
-M	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
in	NULL
G	NULL
;	NULL
and	NULL
were	NULL
isolated	NULL
by	NULL
flow	NULL
cytometric	NULL
sorting	NULL
and	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
p130	NULL
was	NULL
present	NULL
as	NULL
Forms	NULL
1	NULL
and	NULL
2	NULL
in	NULL
both	NULL
S+Gg-M	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
G	NULL
;	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
whereas	NULL
pRb	NULL
was	NULL
hypophosphorylated	NULL
in	NULL
G	NULL
;	NULL
and	NULL
hyperphosphorylated	NULL
in	NULL
S+G	NULL
,	NULL
-M	NULL
(	NULL
Zanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

In	NULL
comparison	NULL
,	NULL
both	NULL
p130	NULL
and	NULL
pRb	NULL
were	NULL
fully	NULL
phosphorylated	NULL
in	NULL
cycling	NULL
cells	NULL
in	NULL
S+G	NULL
,	NULL
-M	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
response	NULL
to	NULL
a-IFN	NULL
,	NULL
the	NULL
initial	NULL
dephosphorylation	NULL
of	NULL
pRb	NULL
and	NULL
p130	NULL
both	NULL
occur	NULL
in	NULL
G	NULL
,	NULL
.	NULL

However	NULL
,	NULL
thereafter	NULL
,	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
p130	NULL
but	NULL
not	NULL
of	NULL
pRb	NULL
is	NULL
regulated	NULL
in	NULL
S+G	NULL
,	NULL
-M.	NULL
Regulation	NULL
of	NULL
p107	NULL
by	NULL
«	NULL
-IFN-We	NULL
fixed	NULL
and	NULL
sorted	NULL
actively	NULL
cycling	NULL
Daudi	NULL
cells	NULL
into	NULL
various	NULL
cell	NULL
cycle	NULL
phases	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
and	NULL
analyzed	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
p107	NULL
by	NULL
Western	NULL
blotting	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
fixing	NULL
and	NULL
sorting	NULL
procedures	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
migration	NULL
of	NULL
p107	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
(	NULL
fixed	NULL
)	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
(	NULL
not	NULL
fixed	NULL
)	NULL
)	NULL
,	NULL
and	NULL
in	NULL
different	NULL
cell	NULL
cycle	NULL
phases	NULL
,	NULL
p107	NULL
is	NULL
hypophosphorylated	NULL
in	NULL
G	NULL
,	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
is	NULL
present	NULL
as	NULL
hypo-	NULL
and	NULL
hyperphosphorylated	NULL
forms	NULL
in	NULL
G	NULL
;	NULL
;	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
and	NULL
is	NULL
hyperphosphorylated	NULL
throughout	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
lanes	NULL
7-9	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
consistent	NULL
with	NULL
p107	NULL
being	NULL
phosphorylated	NULL
in	NULL
late	NULL
G	NULL
,	NULL
in	NULL
cycling	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
timing	NULL
is	NULL
the	NULL
same	NULL
for	NULL
primary	NULL
T-cells	NULL
entering	NULL
the	NULL
cell	NULL
cycle	NULL
for	NULL
the	NULL
first	NULL
time	NULL
from	NULL
G	NULL
,	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
there	NULL
is	NULL
a	NULL
significant	NULL
amount	NULL
of	NULL
hypophosphorylated	NULL
p107	NULL
in	NULL
S	NULL
phase	NULL
when	NULL
fibro-blasts	NULL
are	NULL
stimulated	NULL
to	NULL
enter	NULL
the	NULL
cell	NULL
cycle	NULL
for	NULL
the	NULL
first	NULL
time	NULL
after	NULL
serum	NULL
starvation	NULL
(	NULL
18	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
p107	NULL
becomes	NULL
hypophosphorylated	NULL
in	NULL
S	NULL
phase	NULL
in	NULL
continuously	NULL
cycling	NULL
Daudi	NULL
cells	NULL
,	NULL
we	NULL
isolated	NULL
proliferating	NULL
cells	NULL
in	NULL
both	NULL
early	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
Cell	NULL
Cycle	NULL
Phosphorylation	NULL
of	NULL
the	NULL
pRb	NULL
Family	NULL
3	NULL
p130	NULL
?	NULL

23663	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Phosphorylation	NULL
state	NULL
of	NULL
p130	NULL
during	NULL
cell	NULL
eycle	NULL
arrest	NULL
by	NULL
a-IFN	NULL
.	NULL

A	NULL
,	NULL
Western	NULL
blot	NULL
of	NULL
p180	NULL
in	NULL
Daudi	NULL
cells	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
with	NULL
e-IFN	NULL
in	NULL
G	NULL
,	NULL
(	NULL
lane	NULL
3	NULL
;	NULL
purity	NULL
,	NULL
98	NULL
%	NULL
)	NULL
,	NULL
S	NULL
(	NULL
lane	NULL
4	NULL
;	NULL
purity	NULL
,	NULL
77	NULL
%	NULL
)	NULL
,	NULL
G	NULL
,	NULL
-M	NULL
(	NULL
lane	NULL
5	NULL
;	NULL
purity	NULL
,	NULL
87	NULL
%	NULL
)	NULL
phases	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
or	NULL
a	NULL
total	NULL
cell	NULL
lysate	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
.	NULL

Proliferating	NULL
cell	NULL
lysate	NULL
is	NULL
shown	NULL
in	NULL
lane	NULL
1	NULL
.	NULL

B	NULL
,	NULL
Western	NULL
blots	NULL
of	NULL
p130	NULL
(	NULL
Zanes	NULL
1-4	NULL
)	NULL
and	NULL
pRb	NULL
(	NULL
Zanes	NULL
5-8	NULL
)	NULL
in	NULL
Daudi	NULL
cells	NULL
cultured	NULL
with	NULL
a-IFN	NULL
for	NULL
39	NULL
h	NULL
are	NULL
shown	NULL
as	NULL
follows	NULL
:	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
,	NULL
total	NULL
lysate	NULL
;	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
,	NULL
G	NULL
,	NULL
(	NULL
purity	NULL
,	NULL
98	NULL
%	NULL
)	NULL
;	NULL
lanes	NULL
4	NULL
and	NULL
8	NULL
,	NULL
S+G	NULL
,	NULL
-M	NULL
(	NULL
purity	NULL
,	NULL
66	NULL
%	NULL
)	NULL
.	NULL

Proliferating	NULL
cells	NULL
in	NULL
S+G	NULL
,	NULL
-M	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
5	NULL
)	NULL
are	NULL
shown	NULL
for	NULL
comparison	NULL
.	NULL

(	NULL
Note	NULL
that	NULL
p180	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
is	NULL
the	NULL
same	NULL
as	NULL
that	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
12	NULL
)	NULL
B	NULL
m	NULL
=	NULL
|	NULL
28	NULL
,	NULL
|_	NULL
1	NULL
2	NULL
s	NULL
4	NULL
s	NULL
e	NULL
7	NULL
s	NULL
o	NULL
e=	NULL
C	NULL
|	NULL
.	NULL

vv	NULL
»	NULL
«	NULL
[	NULL
-	NULL
P107	NULL
(	NULL
P	NULL
)	NULL
sss	NULL
-	NULL
hago	NULL
I-	NULL
*-	NULL
»	NULL
~~	NULL
*E	NULL
big	NULL
;	NULL
~	NULL
?	NULL

|	NULL
Sort	NULL
\	NULL
1	NULL
*	NULL
TL	NULL
cle	NULL
aa	NULL
ae	NULL
Purity	NULL
:	NULL
ars	NULL
r|	NULL
\	NULL
ll'lFNN	NULL
C	NULL
?	NULL

@	NULL
¢	NULL
%	NULL
’	NULL
9§0	NULL
%	NULL
--	NULL
-	NULL
ot	NULL
ues	NULL
#	NULL
28	NULL
gﬁfﬂi	NULL
’	NULL
“	NULL
_Sa	NULL
:	NULL
``	NULL
Purity	NULL
:	NULL
51	NULL
%	NULL
Fixed	NULL
[	NULL
fixed	NULL
$	NULL
64	NULL
,	NULL
#	NULL
#	NULL
[	NULL
ﬂ	NULL
C	NULL
oo	NULL
!	NULL

f	NULL
|	NULL
I	NULL
||	NULL
107	NULL
(	NULL
p	NULL
)	NULL
f	NULL
:	NULL
}	NULL
Pu	NULL
P	NULL
G	NULL
I	NULL
JA	NULL
-	NULL
}	NULL
[	NULL
|	NULL
w	NULL
=-	NULL
p1o7	NULL
Purite	NULL
67	NULL
%	NULL
-W	NULL
kentt-	NULL
rae	NULL
o-IFN	NULL
:	NULL
-	NULL
+	NULL
-	NULL
+	NULL
[	NULL
]	NULL
-	NULL
+	NULL
«	NULL
»	NULL
~	NULL
»	NULL
[	NULL
-	NULL
Tubulin	NULL
Fig	NULL
.	NULL

4.	NULL
p107	NULL
in	NULL
proliferating	NULL
and	NULL
a-IFN-arrested	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
proliferating	NULL
Daudi	NULL
cells	NULL
sorted	NULL
into	NULL
the	NULL
cell	NULL
cycle	NULL
phases	NULL
shown	NULL
.	NULL

The	NULL
purity	NULL
is	NULL
indicated	NULL
next	NULL
to	NULL
each	NULL
profile	NULL
.	NULL

B	NULL
,	NULL
p107	NULL
Western	NULL
blots	NULL
of	NULL
the	NULL
sorted	NULL
samples	NULL
shown	NULL
in	NULL
A	NULL
:	NULL
G	NULL
,	NULL
,	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
,	NULL
G	NULL
;	NULL
,	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
early	NULL
S	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
late	NULL
S+G	NULL
,	NULL
-M	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
and	NULL
G	NULL
,	NULL
-M	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

Total	NULL
lysates	NULL
of	NULL
Daudi	NULL
cells	NULL
cultured	NULL
89	NULL
h	NULL
with	NULL
«	NULL
-IFN	NULL
or	NULL
without	NULL
and	NULL
lysed	NULL
directly	NULL
(	NULL
Zanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
or	NULL
fixed	NULL
in	NULL
70	NULL
%	NULL
EtOH	NULL
prior	NULL
to	NULL
lysis	NULL
(	NULL
anes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
The	NULL
positions	NULL
of	NULL
hyper-	NULL
and	NULL
hypophosphorylated	NULL
p107	NULL
(	NULL
p107	NULL
(	NULL
p	NULL
)	NULL
and	NULL
p107	NULL
,	NULL
respectively	NULL
)	NULL
are	NULL
shown	NULL
C	NULL
,	NULL
p107	NULL
Western	NULL
blots	NULL
of	NULL
total	NULL
cell	NULL
lysates	NULL
of	NULL
Daudi	NULL
cells	NULL
cultured	NULL
with	NULL
(	NULL
Zanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
)	NULL
or	NULL
without	NULL
(	NULL
Zanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
)	NULL
a-IFN	NULL
for	NULL
24	NULL
,	NULL
48	NULL
,	NULL
and	NULL
72	NULL
h.	NULL
A	NULL
tubulin	NULL
blot	NULL
of	NULL
samples	NULL
cultured	NULL
for	NULL
72	NULL
h	NULL
+	NULL
«	NULL
-IFN	NULL
is	NULL
shown	NULL
below	NULL
the	NULL
corresponding	NULL
p107	NULL
blot	NULL
.	NULL

and	NULL
late	NULL
S	NULL
phase	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
,	NULL
and	NULL
in	NULL
both	NULL
cases	NULL
,	NULL
pl07	NULL
was	NULL
predominantly	NULL
hyperphosphorylated	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
at	NULL
least	NULL
in	NULL
proliferating	NULL
Daudi	NULL
cells	NULL
,	NULL
p107	NULL
only	NULL
becomes	NULL
hypophosphorylated	NULL
in	NULL
G	NULL
;	NULL
,	NULL
and	NULL
is	NULL
predominantly	NULL
hyperphosphorylated	NULL
from	NULL
G	NULL
»	NULL
throughout	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

In	NULL
response	NULL
to	NULL
«	NULL
-IFN	NULL
,	NULL
p107	NULL
becomes	NULL
hypophosphorylated	NULL
as	NULL
cells	NULL
begin	NULL
to	NULL
arrest	NULL
in	NULL
G	NULL
,	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
(	NULL
-	NULL
«	NULL
-IFN	NULL
)	NULL
;	NULL
lane	NULL
2	NULL
(	NULL
24	NULL
h	NULL
+	NULL
«	NULL
-IFN	NULL
)	NULL
;	NULL
lane	NULL
4	NULL
(	NULL
48	NULL
h	NULL
+	NULL
«	NULL
-IFN	NULL
)	NULL
)	NULL
and	NULL
is	NULL
then	NULL
depleted	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lane	NULL
6	NULL
(	NULL
72	NULL
h	NULL
+	NULL
«	NULL
-IFN	NULL
)	NULL
;	NULL
tubulin	NULL
controls	NULL
are	NULL
shown	NULL
below	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
phosphorylation	NULL
and	NULL
abundance	NULL
of	NULL
p107	NULL
are	NULL
regulated	NULL
by	NULL
a-IFN	NULL
.	NULL

The	NULL
Phosphorylation	NULL
State	NULL
of	NULL
p130	NULL
,	NULL
pRb	NULL
,	NULL
and	NULL
p107	NULL
during	NULL
Cell	NULL
Cycle	NULL
Exit-We	NULL
have	NULL
shown	NULL
above	NULL
that	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
p130	NULL
and	NULL
pRb	NULL
are	NULL
differentially	NULL
regulated	NULL
in	NULL
response	NULL
to	NULL
«	NULL
-IFN	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
this	NULL
is	NULL
peculiar	NULL
to	NULL
a-IFN	NULL
or	NULL
whether	NULL
the	NULL
same	NULL
occurs	NULL
in	NULL
response	NULL
to	NULL
other	NULL
signals	NULL
to	NULL
exit	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
we	NULL
analyzed	NULL
p130	NULL
and	NULL
pRb	NULL
in	NULL
proliferating	NULL
primary	NULL
T-cells	NULL
after	NULL
IL-2	NULL
withdrawal	NULL
,	NULL
in	NULL
Daudi	NULL
cells	NULL
exposed	NULL
to	NULL
a	NULL
suboptimal	NULL
serum	NULL
concentration	NULL
,	NULL
and	NULL
in	NULL
HL60	NULL
myeloid	NULL
cells	NULL
cultured	NULL
with	NULL
RA	NULL
.	NULL

The	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
,	NULL
respectively	NULL
.	NULL

We	NULL
observed	NULL
two	NULL
responses	NULL
:	NULL
(	NULL
i	NULL
)	NULL
p130	NULL
Form	NULL
3	NULL
is	NULL
lost	NULL
before	NULL
pRb	NULL
is	NULL
dephosphorylated	NULL
in	NULL
T-cells	NULL
and	NULL
Daudi	NULL
cells	NULL
withdrawn	NULL
from	NULL
growth	NULL
factors	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
;	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
p130	NULL
Form	NULL
3	NULL
and	NULL
hyperphosphorylated	NULL
pRb	NULL
are	NULL
depleted	NULL
coordinately	NULL
in	NULL
HL6O0	NULL
cells	NULL
between	NULL
days	NULL
3	NULL
and	NULL
4	NULL
after	NULL
RA	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
at	NULL
a	NULL
time	NULL
when	NULL
the	NULL
cells	NULL
arrest	NULL
in	NULL
G	NULL
,	NULL
.	NULL

Therefore	NULL
,	NULL
«	NULL
-IFN	NULL
and	NULL
growth	NULL
factor	NULL
withdrawal	NULL
have	NULL
the	NULL
same	NULL
effect	NULL
,	NULL
causing	NULL
depletion	NULL
of	NULL
p130	NULL
Form	NULL
3	NULL
before	NULL
dephosphorylation	NULL
of	NULL
pRb	NULL
,	NULL
whereas	NULL
we	NULL
have	NULL
not	NULL
detected	NULL
depletion	NULL
of	NULL
p130	NULL
Form	NULL
3	NULL
before	NULL
pRb	NULL
in	NULL
HL6O	NULL
cells	NULL
cultured	NULL
with	NULL
RA	NULL
.	NULL

As	NULL
also	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
p107	NULL
is	NULL
dephosphorylated	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
and	NULL
then	NULL
depleted	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
from	NULL
HL6O	NULL
cells	NULL
between	NULL
days	NULL
3	NULL
and	NULL
4	NULL
with	NULL
RA	NULL
,	NULL
which	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
p107	NULL
in	NULL
Daudi	NULL
cells	NULL
by	NULL
«	NULL
-IFN	NULL
.	NULL

p107	NULL
,	NULL
as	NULL
well	NULL
as	NULL
p130	NULL
and	NULL
pRb	NULL
,	NULL
is	NULL
fully	NULL
phosphorylated	NULL
in	NULL
proliferating	NULL
cells	NULL
cultured	NULL
for	NULL
4	NULL
days	NULL
without	NULL
RA	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

E2F	NULL
Complexes	NULL
in	NULL
«	NULL
-IFN	NULL
Arrested	NULL
Cells-p130	NULL
,	NULL
pRb	NULL
,	NULL
and	NULL
p107	NULL
each	NULL
function	NULL
at	NULL
least	NULL
in	NULL
part	NULL
by	NULL
binding	NULL
to	NULL
E2F	NULL
.	NULL

The	NULL
E2F	NULL
proteins	NULL
can	NULL
be	NULL
grouped	NULL
into	NULL
two	NULL
classes	NULL
,	NULL
E2F-1	NULL
,	NULL
-2	NULL
,	NULL
and	NULL
-3	NULL
and	NULL
E2F-4	NULL
and	NULL
-5	NULL
,	NULL
which	NULL
have	NULL
different	NULL
specificities	NULL
for	NULL
binding	NULL
members	NULL
of	NULL
the	NULL
pRb	NULL
family	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
which	NULL
forms	NULL
of	NULL
p130	NULL
,	NULL
pRb	NULL
,	NULL
and	NULL
p107	NULL
associate	NULL
with	NULL
E2F	NULL
during	NULL
a	NULL
«	NULL
-IFN-mediated	NULL
cell	NULL
cycle	NULL
arrest	NULL
,	NULL
we	NULL
carried	NULL
out	NULL
coimmunoprecipita-tions	NULL
with	NULL
antibodies	NULL
against	NULL
one	NULL
member	NULL
of	NULL
each	NULL
class	NULL
of	NULL
E2F	NULL
,	NULL
namely	NULL
E2F-1	NULL
and	NULL
E2F-4	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
hypophosphorylated	NULL
pRb	NULL
and	NULL
predominantly	NULL
p130	NULL
Form	NULL
1	NULL
were	NULL
coimmunoprecipitated	NULL
with	NULL
E2F-4	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
from	NULL
lysates	NULL
of	NULL
Daudi	NULL
cells	NULL
cultured	NULL
with	NULL
«	NULL
-IFN	NULL
for	NULL
24	NULL
h.	NULL
We	NULL
note	NULL
that	NULL
some	NULL
of	NULL
p130	NULL
Form	NULL
2	NULL
was	NULL
also	NULL
detectable	NULL
on	NULL
longer	NULL
exposures	NULL
but	NULL
none	NULL
of	NULL
Form	NULL
3	NULL
.	NULL

Similar	NULL
data	NULL
were	NULL
obtained	NULL
for	NULL
E2F-5	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
very	NULL
little	NULL
p130	NULL
or	NULL
p107	NULL
and	NULL
no	NULL
detectable	NULL
pRb	NULL
were	NULL
coimmunoprecipitated	NULL
with	NULL
E2F-4	NULL
from	NULL
proliferating	NULL
Daudi	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
and	NULL
no	NULL
p130	NULL
,	NULL
p107	NULL
,	NULL
or	NULL
pRb	NULL
was	NULL
immunoprecipitated	NULL
nonspecifically	NULL
with	NULL
rabbit	NULL
IgG	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
A	NULL
and	NULL
B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

pRb	NULL
coimmunoprecipitated	NULL
with	NULL
E2F-1	NULL
from	NULL
a-IFN	NULL
treated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lane	NULL
9	NULL
)	NULL
,	NULL
and	NULL
a	NULL
small	NULL
amount	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
23664	NULL
Cell	NULL
Cycle	NULL
Phosphorylation	NULL
of	NULL
the	NULL
pRb	NULL
Family	NULL
A	NULL
B	NULL
C	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
1	NULL
2	NULL
3	NULL
1	NULL
2	NULL
3	NULL
4	NULL
%	NULL
-3	NULL
ate	NULL
_	NULL
w	NULL
[	NULL
-	NULL
>	NULL
*	NULL
a	NULL
:	NULL
us	NULL
opt	NULL
a	NULL
?	NULL

p130	NULL
~	NULL
(	NULL
2	NULL
am	NULL
L1	NULL
?	NULL

p130	NULL
``	NULL
:	NULL
%	NULL
me	NULL
-=	NULL
?	NULL

p130	NULL
L	NULL
p	NULL
|-	NULL
___	NULL
.	NULL

E	NULL
pRb	NULL
®	NULL
M	NULL
BL	NULL
``	NULL
ono	NULL
®	NULL
1	NULL
_®	NULL
[	NULL
°	NULL
pro	NULL
0	NULL
18	NULL
24	NULL
48	NULL
72h	NULL
4	NULL
24	NULL
48h	NULL
T-cells	NULL
minus	NULL
IL-2	NULL
Daudi	NULL
<	NULL
=E	NULL
``	NULL
p107	NULL
+0.5	NULL
%	NULL
FCS	NULL
2	NULL
3	NULL
4d	NULL
)	NULL
4d	NULL
RA	NULL
:	NULL
+	NULL
+	NULL
+	NULL
M	NULL
HL6O	NULL
+/-	NULL
RA	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Exit	NULL
from	NULL
the	NULL
cell	NULL
eyele	NULL
.	NULL

A	NULL
,	NULL
human	NULL
primary	NULL
T-cells	NULL
proliferating	NULL
in	NULL
vitro	NULL
were	NULL
washed	NULL
to	NULL
remove	NULL
IL-2	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL
``	NULL

Samples	NULL
were	NULL
taken	NULL
between	NULL
0	NULL
and	NULL
72	NULL
h	NULL
after	NULL
IL-2	NULL
withdrawal	NULL
(	NULL
Zanes	NULL
1-5	NULL
)	NULL
,	NULL
and	NULL
Western	NULL
blots	NULL
for	NULL
p180	NULL
and	NULL
pRb	NULL
were	NULL
done	NULL
.	NULL

B	NULL
,	NULL
proliferating	NULL
Daudi	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
cultured	NULL
in	NULL
RPMI/O0.5	NULL
%	NULL
FCS	NULL
for	NULL
4	NULL
,	NULL
24	NULL
,	NULL
and	NULL
48	NULL
h	NULL
(	NULL
Zanes	NULL
1-3	NULL
)	NULL
.	NULL

Western	NULL
blots	NULL
of	NULL
p180	NULL
and	NULL
pRb	NULL
are	NULL
shown	NULL
.	NULL

C	NULL
,	NULL
HL60	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
RA	NULL
,	NULL
and	NULL
samples	NULL
were	NULL
taken	NULL
for	NULL
p180	NULL
,	NULL
pRb	NULL
,	NULL
and	NULL
p107	NULL
Western	NULL
blots	NULL
(	NULL
Zanes	NULL
1-3	NULL
;	NULL
days	NULL
2-4	NULL
)	NULL
.	NULL

At	NULL
day	NULL
4	NULL
,	NULL
72	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
in	NULL
this	NULL
experiment	NULL
reduced	NULL
nitro	NULL
blue	NULL
tetrazolium	NULL
.	NULL

Cells	NULL
maintained	NULL
for	NULL
4	NULL
days	NULL
without	NULL
RA	NULL
(	NULL
nitro	NULL
blue	NULL
tetrazolium-negative	NULL
)	NULL
are	NULL
shown	NULL
in	NULL
lane	NULL
4	NULL
.	NULL

A	NULL
B	NULL
C	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
1011	NULL
1213	NULL
14	NULL
Mr.	NULL
200	NULL
-I	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
f	NULL
|	NULL
f	NULL
2	NULL
p130	NULL
y*°-	NULL
*	NULL
®	NULL
__	NULL
Ri	NULL
piso	NULL
-	NULL
:	NULL
5	NULL
@	NULL
-	NULL
a	NULL
»	NULL
Zp	NULL
pRb	NULL
so	NULL
.	NULL

@	NULL
a	NULL
1C	NULL
€	NULL
a	NULL
&	NULL
I	NULL
=	NULL
P	NULL
p107	NULL
cut	NULL
:	NULL
-	NULL
»	NULL
o-IFN	NULL
:	NULL
o	NULL
24|0	NULL
24	NULL
40|0	NULL
24|0	NULL
24h	NULL
o	NULL
24	NULL
]	NULL
o	NULL
24	NULL
40|0	NULL
24	NULL
|0	NULL
24h	NULL
ssa	NULL
-|	NULL
a	NULL
R	NULL
F	NULL
'	NULL
_	NULL
e	NULL
E2r-4	NULL
ip	NULL
:	NULL
igo	NULL
|-	NULL
-	NULL
-|e2p-4le2ra	NULL
ip	NULL
:	NULL
1gG	NULL
|-	NULL
-	NULL
-|E2F-4	NULL
]	NULL
E2F-A	NULL
&	NULL
Os	NULL
.	NULL

.	NULL

Total	NULL
cell	NULL
Total	NULL
cell	NULL
&	NULL
lysate	NULL
lysate	NULL
as	NULL
Cell	NULL
lysate	NULL
:	NULL
33	NULL
33	NULL
as	NULL
1.7	NULL
0.3	NULL
)	NULL
,	NULL
|3.3	NULL
331.170.3017	NULL
]	NULL
,	NULL
|33	NULL
33	NULL
x108	NULL
cells	NULL
E2FWT	NULL
:	NULL
'++++	NULL
‘	NULL
:	NULL
-++++f-+	NULL
E2FMUT	NULL
:	NULL
+—	NULL
--	NULL
-f+	NULL
--	NULL
--	NULL
T+—	NULL
T-Calls	NULL
:	NULL
-	NULL
-a-	NULL
GO	NULL
-t	NULL
»	NULL
40h+PHA	NULL
--	NULL
-	NULL
»	NULL
D	NULL
&	NULL
1	NULL
2	NULL
3	NULL
4	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
i.-	NULL
Markt	NULL
_	NULL
]	NULL
~E2F-4	NULL
«	NULL
ap	NULL
0	NULL
24	NULL
96|	NULL
0	NULL
4s	NULL
|24	NULL
24	NULL
h	NULL
Daudi	NULL
CD34+	NULL
cells	NULL
IPaudi	NULL
Daudi	NULL
+o-IFN	NULL
:	NULL
727210	NULL
72h	NULL
+1L-3+1L-6+8CF|+c-IFN	NULL
ﬁlzﬂur	NULL
1	NULL
&	NULL
6	NULL
‘	NULL
&	NULL
|rotat	NULL
can	NULL
Total	NULL
cell	NULL
lysate	NULL
|E2F	NULL
DNA	NULL
E2r	NULL
pna	NULL
|	NULL
lysate	NULL
site	NULL
site	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

E2F	NULL
complexes	NULL
with	NULL
p130	NULL
,	NULL
pRb	NULL
and	NULL
p107	NULL
.	NULL

A	NULL
and	NULL
B	NULL
,	NULL
Daudi	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
(	NULL
James	NULL
2	NULL
,	NULL
7	NULL
,	NULL
and	NULL
9	NULL
)	NULL
or	NULL
without	NULL
(	NULL
Zanes	NULL
1	NULL
,	NULL
6	NULL
,	NULL
and	NULL
8	NULL
)	NULL
e-IFN	NULL
for	NULL
24	NULL
h	NULL
,	NULL
E2F-1	NULL
(	NULL
Zanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
and	NULL
E2F-4	NULL
(	NULL
Zanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
were	NULL
immunoprecipitated	NULL
,	NULL
and	NULL
Western	NULL
blots	NULL
of	NULL
pRb	NULL
(	NULL
A	NULL
)	NULL
,	NULL
p130	NULL
,	NULL
and	NULL
p107	NULL
(	NULL
B	NULL
)	NULL
were	NULL
done	NULL
.	NULL

Control	NULL
immunoprecipitations	NULL
with	NULL
rabbit	NULL
IgG	NULL
(	NULL
Zanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
and	NULL
total	NULL
lysates	NULL
of	NULL
cells	NULL
cultured	NULL
with	NULL
a-IFN	NULL
for	NULL
0	NULL
,	NULL
24	NULL
,	NULL
and	NULL
40	NULL
h	NULL
(	NULL
Zanes	NULL
3-5	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

In	NULL
B	NULL
,	NULL
the	NULL
same	NULL
blot	NULL
was	NULL
probed	NULL
first	NULL
for	NULL
p107	NULL
and	NULL
reprobed	NULL
for	NULL
p180	NULL
.	NULL

C	NULL
,	NULL
forms	NULL
of	NULL
p180	NULL
and	NULL
E2F-4	NULL
that	NULL
bind	NULL
DNA	NULL
.	NULL

Lysates	NULL
of	NULL
0.8-83	NULL
X	NULL
10°	NULL
quiescent	NULL
primary	NULL
T-cells	NULL
(	NULL
Janes	NULL
2-5	NULL
)	NULL
or	NULL
0.17-88	NULL
X	NULL
10°	NULL
cells	NULL
cultured	NULL
for	NULL
40	NULL
h	NULL
+PHA	NULL
(	NULL
Zanes	NULL
8-11	NULL
and	NULL
14	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
and	NULL
E2F	NULL
``	NULL
``	NULL
DNA	NULL
binding	NULL
site	NULL
coupled	NULL
to	NULL
beads	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
,	NULL
``	NULL
and	NULL
the	NULL
proteins	NULL
bound	NULL
were	NULL
analyzed	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

The	NULL
Western	NULL
blot	NULL
was	NULL
cut	NULL
in	NULL
half	NULL
and	NULL
probed	NULL
for	NULL
p180	NULL
(	NULL
upper	NULL
)	NULL
and	NULL
E2F-4	NULL
(	NULL
lower	NULL
)	NULL
.	NULL

p130	NULL
and	NULL
E2F-4	NULL
in	NULL
83	NULL
X	NULL
10°	NULL
quiescent	NULL
T-cells	NULL
or	NULL
in	NULL
8.8	NULL
or	NULL
83	NULL
x	NULL
10°	NULL
T-cells	NULL
+PHA	NULL
that	NULL
binds	NULL
a	NULL
mutant	NULL
E2F	NULL
DNA	NULL
site	NULL
are	NULL
shown	NULL
in	NULL
Zanes	NULL
1	NULL
,	NULL
7	NULL
and	NULL
13	NULL
,	NULL
respectively	NULL
.	NULL

Lanes	NULL
6	NULL
and	NULL
12	NULL
,	NULL
total	NULL
cell	NULL
lysate	NULL
of	NULL
T-cells	NULL
+PHA	NULL
.	NULL

The	NULL
samples	NULL
shown	NULL
in	NULL
lanes	NULL
1-11	NULL
and	NULL
12-14	NULL
are	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

D	NULL
,	NULL
E2F-4	NULL
in	NULL
Daudi	NULL
cells	NULL
+a-IFN	NULL
.	NULL

Western	NULL
blots	NULL
of	NULL
total	NULL
cell	NULL
lysates	NULL
of	NULL
CD84+	NULL
primary	NULL
hemopoietic	NULL
progenitor	NULL
cells	NULL
cultured	NULL
for	NULL
0-4	NULL
days	NULL
with	NULL
SCF	NULL
,	NULL
IL-3	NULL
,	NULL
and	NULL
IL-6	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
and	NULL
of	NULL
Daudi	NULL
cells	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
*+a-IFN	NULL
(	NULL
Zanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
were	NULL
probed	NULL
for	NULL
E2F-4	NULL
.	NULL

Lanes	NULL
6	NULL
and	NULL
7	NULL
are	NULL
of	NULL
E2F-4	NULL
in	NULL
Daudi	NULL
cells	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
+	NULL
«	NULL
-IFN	NULL
that	NULL
binds	NULL
an	NULL
E2FY	NULL
``	NULL
or	NULL
E2FYY	NULL
``	NULL
DNA	NULL
binding	NULL
site	NULL
,	NULL
respectively	NULL
.	NULL

Lames	NULL
1-5	NULL
and	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
were	NULL
run	NULL
on	NULL
separate	NULL
gels	NULL
.	NULL

E	NULL
,	NULL
p130	NULL
and	NULL
pRb	NULL
in	NULL
a-IFN-arrested	NULL
Daudi	NULL
cells	NULL
that	NULL
bind	NULL
DNA	NULL
.	NULL

The	NULL
forms	NULL
of	NULL
pRb	NULL
and	NULL
p180	NULL
in	NULL
extracts	NULL
of	NULL
Daudi	NULL
cells	NULL
cultured	NULL
for	NULL
72	NULL
h	NULL
+a-IFN	NULL
that	NULL
bind	NULL
E2F	NULL
``	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
or	NULL
E2FYYT	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
DNA	NULL
binding	NULL
sites	NULL
were	NULL
determined	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

Total	NULL
cell	NULL
lysates	NULL
of	NULL
proliferating	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
and	NULL
cells	NULL
cultured	NULL
for	NULL
72	NULL
h	NULL
+	NULL
«	NULL
-IFN	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
are	NULL
shown	NULL
for	NULL
comparison	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
probed	NULL
sequentially	NULL
for	NULL
pRb	NULL
then	NULL
p130	NULL
.	NULL

was	NULL
detected	NULL
in	NULL
proliferating	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

However	NULL
,	NULL
no	NULL
p130	NULL
or	NULL
p107	NULL
was	NULL
detected	NULL
coommunoprecipitating	NULL
with	NULL
E2F-1	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
,	NULL
lanes	NULL
8	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
pRb	NULL
communoprecipitates	NULL
with	NULL
both	NULL
E2F-1	NULL
and	NULL
-4	NULL
form	NULL
lysates	NULL
of	NULL
Daudi	NULL
cells	NULL
cultured	NULL
with	NULL
a-IFN	NULL
,	NULL
whereas	NULL
p130	NULL
and	NULL
p107	NULL
only	NULL
bind	NULL
E2F-4	NULL
.	NULL

The	NULL
coimmunoprecipitation	NULL
data	NULL
show	NULL
the	NULL
forms	NULL
of	NULL
p130	NULL
,	NULL
p107	NULL
,	NULL
and	NULL
pRb	NULL
,	NULL
which	NULL
can	NULL
be	NULL
isolated	NULL
in	NULL
complexes	NULL
with	NULL
different	NULL
E2Fs	NULL
from	NULL
lysates	NULL
of	NULL
«	NULL
-IFN	NULL
treated	NULL
cells	NULL
.	NULL

Formation	NULL
of	NULL
these	NULL
complexes	NULL
in	NULL
response	NULL
to	NULL
a	NULL
«	NULL
-IFN	NULL
may	NULL
depend	NULL
not	NULL
only	NULL
on	NULL
changes	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
pRb	NULL
family	NULL
but	NULL
also	NULL
of	NULL
the	NULL
E2F	NULL
.	NULL

Because	NULL
the	NULL
functional	NULL
forms	NULL
of	NULL
such	NULL
complexes	NULL
are	NULL
thought	NULL
to	NULL
be	NULL
those	NULL
that	NULL
are	NULL
bound	NULL
to	NULL
an	NULL
E2F	NULL
DNA	NULL
binding	NULL
site	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
form	NULL
(	NULL
s	NULL
)	NULL
of	NULL
E2F	NULL
and	NULL
pRb	NULL
family	NULL
members	NULL
that	NULL
bind	NULL
DNA	NULL
.	NULL

Thus	NULL
,	NULL
cell	NULL
lysates	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
biotinylated	NULL
E2F	NULL
DNA	NULL
binding	NULL
site	NULL
(	NULL
E2FY*	NULL
)	NULL
bound	NULL
to	NULL
avidin-beads	NULL
(	NULL
see	NULL
under	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
)	NULL
,	NULL
and	NULL
the	NULL
forms	NULL
of	NULL
each	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
Cell	NULL
Cycle	NULL
Phosphorylation	NULL
of	NULL
the	NULL
pRb	NULL
Family	NULL
protein	NULL
bound	NULL
were	NULL
determined	NULL
by	NULL
Western	NULL
blotting	NULL
.	NULL

Note	NULL
that	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
pRb	NULL
family	NULL
,	NULL
the	NULL
migration	NULL
of	NULL
E2F-4	NULL
in	NULL
SDS-PAGE	NULL
also	NULL
changes	NULL
as	NULL
a	NULL
result	NULL
of	NULL
differences	NULL
in	NULL
its	NULL
phosphorylation	NULL
state	NULL
(	NULL
17	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Because	NULL
we	NULL
had	NULL
shown	NULL
previously	NULL
(	NULL
24	NULL
)	NULL
that	NULL
primary	NULL
hemopoietic	NULL
cells	NULL
in	NULL
G	NULL
,	NULL
and	NULL
during	NULL
active	NULL
proliferation	NULL
contain	NULL
different	NULL
phosphorylated	NULL
forms	NULL
of	NULL
E2F-4	NULL
,	NULL
we	NULL
therefore	NULL
used	NULL
lysates	NULL
of	NULL
freshly	NULL
isolated	NULL
primary	NULL
T-cells	NULL
(	NULL
in	NULL
G	NULL
,	NULL
)	NULL
and	NULL
T-cells	NULL
40	NULL
h	NULL
after	NULL
stimulation	NULL
with	NULL
PHA	NULL
(	NULL
in	NULL
late	NULL
G	NULL
,	NULL
)	NULL
to	NULL
determine	NULL
which	NULL
forms	NULL
of	NULL
p130	NULL
and	NULL
E2F-4	NULL
can	NULL
bind	NULL
an	NULL
E2F	NULL
DNA	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

6C	NULL
show	NULL
that	NULL
p130	NULL
Forms	NULL
1	NULL
and	NULL
2	NULL
and	NULL
hyperphosphorylated	NULL
E2F-4	NULL
in	NULL
lysates	NULL
of	NULL
cells	NULL
in	NULL
G	NULL
,	NULL
bind	NULL
the	NULL
E2FY	NULL
``	NULL
DNA	NULL
(	NULL
Zanes	NULL
2-5	NULL
)	NULL
,	NULL
but	NULL
not	NULL
to	NULL
a	NULL
mutant	NULL
E2F	NULL
site	NULL
(	NULL
E2FYY	NULL
``	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

After	NULL
40	NULL
h	NULL
+PHA	NULL
,	NULL
p130	NULL
Form	NULL
3	NULL
predominates	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
12	NULL
,	NULL
total	NULL
lysate	NULL
)	NULL
,	NULL
and	NULL
as	NULL
expected	NULL
,	NULL
this	NULL
form	NULL
does	NULL
not	NULL
bind	NULL
DNA	NULL
(	NULL
Zanes	NULL
8-11	NULL
and	NULL
14	NULL
)	NULL
.	NULL

Multiple	NULL
,	NULL
hypophosphorylated	NULL
forms	NULL
of	NULL
E2F-4	NULL
are	NULL
present	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Zanes	NULL
6	NULL
and	NULL
12	NULL
)	NULL
,	NULL
which	NULL
bind	NULL
E2FY	NULL
``	NULL
*	NULL
DNA	NULL
(	NULL
Zanes	NULL
8-11	NULL
and	NULL
14	NULL
)	NULL
but	NULL
not	NULL
E2FPYVY	NULL
``	NULL
*	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
13	NULL
)	NULL
.	NULL

The	NULL
forms	NULL
of	NULL
each	NULL
protein	NULL
that	NULL
bind	NULL
the	NULL
E2F	NULL
DNA	NULL
site	NULL
from	NULL
lysates	NULL
of	NULL
Daudi	NULL
cells	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
a-IFN	NULL
were	NULL
then	NULL
determined	NULL
,	NULL
and	NULL
cell	NULL
extracts	NULL
within	NULL
the	NULL
linear	NULL
range	NULL
of	NULL
the	NULL
binding	NULL
assay	NULL
were	NULL
used	NULL
(	NULL
as	NULL
determined	NULL
in	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

Predominantly	NULL
p130	NULL
Form	NULL
1	NULL
(	NULL
with	NULL
some	NULL
Form	NULL
2	NULL
but	NULL
no	NULL
Form	NULL
3	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
hypophosphorylated	NULL
pRb	NULL
(	NULL
Fig	NULL
.	NULL

6K	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
and	NULL
multiple	NULL
hypophosphorylated	NULL
forms	NULL
of	NULL
E2F-4	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
bind	NULL
DNA	NULL
.	NULL

Note	NULL
that	NULL
little	NULL
or	NULL
no	NULL
protein	NULL
binds	NULL
the	NULL
E2FPYYT	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
D	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
and	NULL
E	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
)	NULL
.	NULL

Hypophosphorylated	NULL
p107	NULL
also	NULL
binds	NULL
E2FY	NULL
``	NULL
DNA	NULL
from	NULL
lysates	NULL
of	NULL
Daudi	NULL
cells	NULL
cultured	NULL
for	NULL
24	NULL
h	NULL
with	NULL
«	NULL
-IFN	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
forms	NULL
of	NULL
the	NULL
pRb	NULL
family	NULL
that	NULL
bind	NULL
E2F*	NULL
``	NULL
DNA	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
forms	NULL
that	NULL
communoprecipitate	NULL
with	NULL
E2F-4	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
forms	NULL
of	NULL
E2F-4	NULL
present	NULL
in	NULL
«	NULL
-IFN-treated	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
that	NULL
bind	NULL
E2F*	NULL
``	NULL
*	NULL
DNA	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
comigrate	NULL
with	NULL
the	NULL
forms	NULL
present	NULL
in	NULL
lysates	NULL
of	NULL
proliferating	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
and	NULL
even	NULL
after	NULL
prolonged	NULL
incubations	NULL
with	NULL
a-IFN	NULL
,	NULL
we	NULL
detected	NULL
little	NULL
or	NULL
no	NULL
hyperphosphorylated	NULL
E2F-4	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Lysates	NULL
of	NULL
CD34+	NULL
primary	NULL
hemopoietic	NULL
progenitor	NULL
cells	NULL
run	NULL
on	NULL
the	NULL
same	NULL
gel	NULL
are	NULL
shown	NULL
for	NULL
comparison	NULL
because	NULL
they	NULL
contain	NULL
hyperphosphorylated	NULL
E2F-4	NULL
at	NULL
¢	NULL
=	NULL
0	NULL
but	NULL
not	NULL
after	NULL
4	NULL
days	NULL
in	NULL
culture	NULL
with	NULL
SCF	NULL
,	NULL
IL-3	NULL
,	NULL
and	NULL
IL-6	NULL
(	NULL
24	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
,	NULL
lanes	NULL
1-3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
changes	NULL
in	NULL
the	NULL
association	NULL
of	NULL
E2F-4	NULL
with	NULL
different	NULL
pRb	NULL
family	NULL
members	NULL
in	NULL
response	NULL
to	NULL
«	NULL
-IFN	NULL
,	NULL
detected	NULL
either	NULL
by	NULL
communoprecipitation	NULL
or	NULL
by	NULL
E2FY	NULL
``	NULL
DNA	NULL
binding	NULL
,	NULL
are	NULL
not	NULL
due	NULL
to	NULL
gross	NULL
changes	NULL
in	NULL
E2F-4	NULL
phosphorylation	NULL
,	NULL
and	NULL
«	NULL
-IFN	NULL
does	NULL
not	NULL
cause	NULL
hyperphosphorylation	NULL
of	NULL
E2F-4	NULL
to	NULL
that	NULL
which	NULL
is	NULL
present	NULL
in	NULL
primary	NULL
hemopoietic	NULL
cells	NULL
in	NULL
Gy	NULL
.	NULL

DISCUSSION	NULL
Many	NULL
proteins	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
controlling	NULL
cell	NULL
proliferation	NULL
are	NULL
regulated	NULL
in	NULL
susceptible	NULL
cells	NULL
by	NULL
-IFN	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

70	NULL
)	NULL
.	NULL

The	NULL
Daudi	NULL
B-cell	NULL
line	NULL
has	NULL
been	NULL
used	NULL
for	NULL
a	NULL
number	NULL
of	NULL
these	NULL
studies	NULL
because	NULL
it	NULL
is	NULL
sensitive	NULL
to	NULL
growth	NULL
arrest	NULL
by	NULL
«	NULL
-IFN	NULL
.	NULL

Proliferating	NULL
Daudi	NULL
cells	NULL
cultured	NULL
with	NULL
«	NULL
-IFN	NULL
arrest	NULL
in	NULL
G	NULL
,	NULL
,	NULL
and	NULL
this	NULL
is	NULL
accompanied	NULL
by	NULL
the	NULL
dephosphorylation	NULL
of	NULL
pRb	NULL
to	NULL
a	NULL
hypophosphorylated	NULL
form	NULL
(	NULL
5	NULL
,	NULL
7	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Recently	NULL
(	NULL
62	NULL
)	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
this	NULL
causes	NULL
pRb	NULL
to	NULL
complex	NULL
with	NULL
E2F-1	NULL
and	NULL
E2F-4	NULL
,	NULL
and	NULL
it	NULL
was	NULL
suggested	NULL
that	NULL
this	NULL
results	NULL
in	NULL
repression	NULL
of	NULL
E2F	NULL
-containing	NULL
promoters	NULL
,	NULL
such	NULL
as	NULL
those	NULL
in	NULL
the	NULL
ede2	NULL
and	NULL
c-myc	NULL
genes	NULL
.	NULL

We	NULL
showed	NULL
previously	NULL
(	NULL
5	NULL
)	NULL
that	NULL
in	NULL
response	NULL
to	NULL
«	NULL
-IFN	NULL
,	NULL
pRb	NULL
is	NULL
dephosphorylated	NULL
only	NULL
in	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
and	NULL
so	NULL
it	NULL
is	NULL
only	NULL
able	NULL
to	NULL
repress	NULL
E2F	NULL
activity	NULL
once	NULL
proliferating	NULL
cells	NULL
have	NULL
entered	NULL
G	NULL
;	NULL
.	NULL

pRb	NULL
is	NULL
the	NULL
first	NULL
member	NULL
of	NULL
a	NULL
family	NULL
of	NULL
proteins	NULL
that	NULL
also	NULL
includes	NULL
p130	NULL
and	NULL
p107	NULL
,	NULL
each	NULL
of	NULL
which	NULL
can	NULL
bind	NULL
and	NULL
repress	NULL
E2F	NULL
's	NULL
(	NULL
3	NULL
,	NULL
23	NULL
)	NULL
.	NULL

In	NULL
the	NULL
study	NULL
presented	NULL
here	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
«	NULL
-IFN	NULL
regulates	NULL
p130	NULL
and	NULL
p107	NULL
and	NULL
to	NULL
what	NULL
extent	NULL
their	NULL
regulation	NULL
is	NULL
also	NULL
cell	NULL
cycle-dependent	NULL
.	NULL

We	NULL
determined	NULL
first	NULL
whether	NULL
the	NULL
phosphorylation	NULL
states	NULL
of	NULL
283665	NULL
pRb	NULL
,	NULL
p130	NULL
,	NULL
and	NULL
p107	NULL
are	NULL
regulated	NULL
in	NULL
different	NULL
cell	NULL
cycle	NULL
phases	NULL
during	NULL
continuous	NULL
proliferation	NULL
.	NULL

Second	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
dephosphorylation	NULL
of	NULL
each	NULL
is	NULL
regulated	NULL
coordinately	NULL
during	NULL
«	NULL
-IFN-mediated	NULL
cell	NULL
cycle	NULL
arrest	NULL
.	NULL

To	NULL
answer	NULL
these	NULL
ques-tions	NULL
,	NULL
we	NULL
employed	NULL
a	NULL
rapid	NULL
fixation	NULL
method	NULL
,	NULL
followed	NULL
by	NULL
flow	NULL
cytometric	NULL
sorting	NULL
and	NULL
Western	NULL
blotting	NULL
,	NULL
a	NULL
protocol	NULL
that	NULL
we	NULL
have	NULL
used	NULL
previously	NULL
to	NULL
analyze	NULL
pRb	NULL
(	NULL
5	NULL
)	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
here	NULL
that	NULL
(	NULL
i	NULL
)	NULL
in	NULL
actively	NULL
cycling	NULL
Daudi	NULL
cells	NULL
,	NULL
p130	NULL
is	NULL
present	NULL
predominantly	NULL
as	NULL
phosphorylated	NULL
Form	NULL
3	NULL
in	NULL
all	NULL
cell	NULL
cycle	NULL
phases	NULL
.	NULL

p107	NULL
is	NULL
hypophosphorylated	NULL
in	NULL
G	NULL
,	NULL
,	NULL
,	NULL
becomes	NULL
hyperphosphorylated	NULL
in	NULL
and	NULL
remains	NULL
fully	NULL
phosphorylated	NULL
throughout	NULL
the	NULL
remainder	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
p107	NULL
during	NULL
G	NULL
;	NULL
is	NULL
similar	NULL
to	NULL
pRb	NULL
,	NULL
except	NULL
that	NULL
pRb	NULL
is	NULL
partially	NULL
phosphorylated	NULL
in	NULL
G	NULL
;	NULL
,	NULL
(	NULL
not	NULL
hypophosphorylated	NULL
)	NULL
and	NULL
is	NULL
hyperphosphorylated	NULL
from	NULL
G	NULL
;	NULL
»	NULL
;	NULL
onwards	NULL
(	NULL
5	NULL
)	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
In	NULL
cells	NULL
arrested	NULL
with	NULL
a	NULL
«	NULL
-IFN	NULL
,	NULL
p130	NULL
Form	NULL
3	NULL
is	NULL
depleted	NULL
,	NULL
possibly	NULL
by	NULL
de-phosphorylation	NULL
,	NULL
and	NULL
principally	NULL
Form	NULL
1	NULL
,	NULL
with	NULL
some	NULL
Form	NULL
2	NULL
,	NULL
predominates	NULL
in	NULL
every	NULL
cell	NULL
cycle	NULL
phase	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
pRb	NULL
is	NULL
dephosphorylated	NULL
to	NULL
a	NULL
hypophosphorylated	NULL
state	NULL
only	NULL
in	NULL
G	NULL
;	NULL
.	NULL

p107	NULL
is	NULL
dephosphorylated	NULL
and	NULL
then	NULL
depleted	NULL
.	NULL

p130	NULL
Form	NULL
1	NULL
and	NULL
hypophosphorylated	NULL
p107	NULL
coimmunoprecipitate	NULL
with	NULL
E2F-4	NULL
from	NULL
lysates	NULL
of	NULL
«	NULL
-IFN-treated	NULL
Daudi	NULL
cells	NULL
.	NULL

Hypophosphorylated	NULL
pRb	NULL
coimmunoprecipitates	NULL
with	NULL
both	NULL
E2F-4	NULL
and	NULL
E2F-1	NULL
.	NULL

These	NULL
forms	NULL
of	NULL
p130	NULL
and	NULL
pRb	NULL
bind	NULL
to	NULL
an	NULL
Y	NULL
``	NULL
DNA	NULL
binding	NULL
site	NULL
.	NULL

The	NULL
difference	NULL
between	NULL
the	NULL
amounts	NULL
of	NULL
p130	NULL
,	NULL
p107	NULL
,	NULL
and	NULL
pRb	NULL
coimmunoprecipitated	NULL
with	NULL
E2F-4	NULL
from	NULL
proliferating	NULL
and	NULL
a-IFN-treated	NULL
cells	NULL
is	NULL
most	NULL
probably	NULL
due	NULL
to	NULL
changes	NULL
in	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
pRb	NULL
,	NULL
p130	NULL
,	NULL
and	NULL
p107	NULL
rather	NULL
than	NULL
to	NULL
gross	NULL
changes	NULL
in	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
E2F-4	NULL
.	NULL

Thus	NULL
,	NULL
«	NULL
-IFN	NULL
may	NULL
bring	NULL
about	NULL
cell	NULL
cycle	NULL
arrest	NULL
not	NULL
only	NULL
through	NULL
pRb	NULL
but	NULL
also	NULL
by	NULL
regulating	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
p130	NULL
and	NULL
the	NULL
abundance	NULL
of	NULL
p107	NULL
.	NULL

Several	NULL
studies	NULL
have	NULL
investigated	NULL
the	NULL
E2F	NULL
complexes	NULL
that	NULL
are	NULL
present	NULL
as	NULL
cells	NULL
enter	NULL
the	NULL
cell	NULL
cycle	NULL
from	NULL
a	NULL
resting	NULL
state	NULL
(	NULL
see	NULL
Ref	NULL
.	NULL

26	NULL
and	NULL
references	NULL
therein	NULL
)	NULL
.	NULL

Their	NULL
function	NULL
is	NULL
presumed	NULL
to	NULL
be	NULL
to	NULL
induce	NULL
the	NULL
orderly	NULL
transcription	NULL
of	NULL
specific	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
those	NULL
encoding	NULL
thymidine	NULL
kinase	NULL
and	NULL
edc2	NULL
,	NULL
which	NULL
are	NULL
required	NULL
for	NULL
progression	NULL
into	NULL
S	NULL
phase	NULL
and	NULL
for	NULL
controlling	NULL
passage	NULL
through	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
22	NULL
)	NULL
.	NULL

This	NULL
may	NULL
be	NULL
true	NULL
for	NULL
entry	NULL
into	NULL
the	NULL
first	NULL
cell	NULL
cycle	NULL
.	NULL

However	NULL
,	NULL
once	NULL
in	NULL
cycle	NULL
the	NULL
abundance	NULL
of	NULL
,	NULL
for	NULL
example	NULL
,	NULL
cdc2	NULL
changes	NULL
only	NULL
in	NULL
line	NULL
with	NULL
the	NULL
total	NULL
amount	NULL
of	NULL
cellular	NULL
protein	NULL
(	NULL
71-73	NULL
)	NULL
.	NULL
``	NULL

Therefore	NULL
,	NULL
regulation	NULL
of	NULL
E2F	NULL
activity	NULL
by	NULL
the	NULL
pRb	NULL
family	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
different	NULL
in	NULL
cells	NULL
entering	NULL
the	NULL
cell	NULL
cycle	NULL
for	NULL
the	NULL
first	NULL
time	NULL
and	NULL
in	NULL
those	NULL
proliferating	NULL
continu-ously	NULL
.	NULL

Cycling	NULL
cells	NULL
contained	NULL
predominantly	NULL
phosphorylated	NULL
p130	NULL
Form	NULL
3	NULL
in	NULL
all	NULL
cell	NULL
cycle	NULL
phases	NULL
from	NULL
G	NULL
;	NULL
,	NULL
through	NULL
to	NULL
G	NULL
,	NULL
-M	NULL
.	NULL

This	NULL
form	NULL
does	NULL
not	NULL
bind	NULL
E2F	NULL
complexes	NULL
and	NULL
was	NULL
not	NULL
isolated	NULL
by	NULL
binding	NULL
to	NULL
an	NULL
E2F	NULL
DNA	NULL
binding	NULL
site	NULL
.	NULL

Because	NULL
p130	NULL
only	NULL
binds	NULL
E2Fs	NULL
and	NULL
DNA	NULL
when	NULL
it	NULL
is	NULL
in	NULL
Forms	NULL
1	NULL
and	NULL
2	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
p130	NULL
has	NULL
no	NULL
major	NULL
role	NULL
in	NULL
controlling	NULL
E2F	NULL
function	NULL
in	NULL
Daudi	NULL
cells	NULL
during	NULL
continuous	NULL
proliferation	NULL
.	NULL

Our	NULL
conclusions	NULL
differ	NULL
from	NULL
those	NULL
published	NULL
recently	NULL
that	NULL
showed	NULL
that	NULL
a	NULL
p130-E2F	NULL
complex	NULL
exists	NULL
during	NULL
G	NULL
,	NULL
(	NULL
74	NULL
)	NULL
.	NULL

It	NULL
is	NULL
not	NULL
clear	NULL
whether	NULL
there	NULL
are	NULL
differences	NULL
because	NULL
of	NULL
the	NULL
cell	NULL
types	NULL
or	NULL
the	NULL
methods	NULL
used	NULL
in	NULL
the	NULL
two	NULL
studies	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
our	NULL
data	NULL
show	NULL
that	NULL
p130	NULL
is	NULL
phosphorylated	NULL
as	NULL
quiescent	NULL
primary	NULL
CD34+	NULL
hemopoietic	NULL
progenitors	NULL
(	NULL
24	NULL
)	NULL
and	NULL
T-cells	NULL
exit	NULL
G	NULL
,	NULL
and	NULL
enter	NULL
G	NULL
;	NULL
4	NULL
,	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
p130	NULL
maintains	NULL
cells	NULL
in	NULL
G	NULL
,	NULL
(	NULL
14	NULL
,	NULL
17	NULL
,	NULL
37	NULL
)	NULL
,	NULL
and	NULL
inactivation	NULL
of	NULL
p130	NULL
by	NULL
phosphorylation	NULL
upon	NULL
entry	NULL
into	NULL
G	NULL
;	NULL
,	NULL
is	NULL
most	NULL
consistent	NULL
with	NULL
p130	NULL
having	NULL
a	NULL
role	NULL
in	NULL
allowing	NULL
the	NULL
transition	NULL
from	NULL
rather	NULL
than	NULL
controlling	NULL
progression	NULL
through	NULL
G	NULL
;	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
p130	NULL
,	NULL
both	NULL
pRb	NULL
and	NULL
p107	NULL
in	NULL
actively	NULL
cycling	NULL
cells	NULL
are	NULL
dephosphorylated	NULL
during	NULL
G	NULL
;	NULL
,	NULL
(	NULL
pRb	NULL
partially	NULL
)	NULL
and	NULL
are	NULL
fully	NULL
phosphorylated	NULL
from	NULL
the	NULL
G	NULL
,	NULL
-S	NULL
border	NULL
onwards	NULL
.	NULL

Thus	NULL
,	NULL
both	NULL
°8	NULL
.	NULL

Tiwari	NULL
and	NULL
N.	NULL
S.	NULL
B.	NULL
Thomas	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
23666	NULL
could	NULL
have	NULL
a	NULL
role	NULL
to	NULL
play	NULL
in	NULL
G	NULL
,	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
pl07-E2F	NULL
complexes	NULL
are	NULL
present	NULL
in	NULL
the	NULL
cytosol	NULL
during	NULL
G	NULL
;	NULL
,	NULL
whereas	NULL
pRb-E2F	NULL
complexes	NULL
are	NULL
nuclear	NULL
(	NULL
74	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
p107	NULL
in	NULL
actively	NULL
cycling	NULL
Daudi	NULL
cells	NULL
may	NULL
bind	NULL
E2F	NULL
(	NULL
E2F-4	NULL
and	NULL
-5	NULL
)	NULL
in	NULL
a	NULL
cytosolic	NULL
form	NULL
during	NULL
which	NULL
is	NULL
released	NULL
as	NULL
p107	NULL
becomes	NULL
phosphorylated	NULL
in	NULL
G	NULL
;	NULL
p.	NULL
In	NULL
contrast	NULL
to	NULL
p107	NULL
,	NULL
pRb	NULL
can	NULL
only	NULL
be	NULL
hypophosphorylated	NULL
for	NULL
a	NULL
brief	NULL
period	NULL
during	NULL
G14	NULL
,	NULL
because	NULL
we	NULL
detected	NULL
multiple	NULL
,	NULL
partially	NULL
phosphorylated	NULL
forms	NULL
in	NULL
this	NULL
sub-phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

We	NULL
have	NULL
not	NULL
detected	NULL
these	NULL
phosphorylated	NULL
forms	NULL
bound	NULL
to	NULL
E2F	NULL
or	NULL
to	NULL
an	NULL
DNA	NULL
site	NULL
,	NULL
and	NULL
it	NULL
is	NULL
possible	NULL
therefore	NULL
that	NULL
other	NULL
proteins	NULL
in	NULL
the	NULL
cell	NULL
(	NULL
23	NULL
,	NULL
75	NULL
)	NULL
are	NULL
regulated	NULL
by	NULL
these	NULL
forms	NULL
of	NULL
pRb	NULL
,	NULL
but	NULL
this	NULL
has	NULL
yet	NULL
to	NULL
be	NULL
shown	NULL
.	NULL

Once	NULL
cells	NULL
have	NULL
progressed	NULL
through	NULL
G4	NULL
,	NULL
the	NULL
data	NULL
presented	NULL
here	NULL
show	NULL
that	NULL
both	NULL
p107	NULL
and	NULL
pRb	NULL
are	NULL
predominantly	NULL
hyperphosphorylated	NULL
throughout	NULL
S	NULL
and	NULL
G	NULL
,	NULL
-M.	NULL
Our	NULL
data	NULL
on	NULL
pRb	NULL
are	NULL
consistent	NULL
with	NULL
dissociation	NULL
of	NULL
pRb	NULL
and	NULL
E2F	NULL
during	NULL
the	NULL
G	NULL
,	NULL
;	NULL
-S	NULL
phase	NULL
transition	NULL
reported	NULL
previously	NULL
(	NULL
see	NULL
Ref	NULL
.	NULL

2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
p107-E2F	NULL
complexes	NULL
have	NULL
been	NULL
detected	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
in	NULL
extracts	NULL
of	NULL
cells	NULL
from	NULL
late	NULL
G	NULL
,	NULL
into	NULL
S	NULL
phase	NULL
(	NULL
21	NULL
,	NULL
74	NULL
,	NULL
76	NULL
)	NULL
,	NULL
and	NULL
p107	NULL
has	NULL
also	NULL
been	NULL
reported	NULL
to	NULL
become	NULL
dephosphorylated	NULL
again	NULL
late	NULL
in	NULL
S	NULL
phase	NULL
(	NULL
18	NULL
)	NULL
.	NULL

From	NULL
the	NULL
data	NULL
presented	NULL
here	NULL
and	NULL
from	NULL
hydroxyurea	NULL
block/release	NULL
experiments	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
we	NULL
would	NULL
suggest	NULL
that	NULL
because	NULL
most	NULL
of	NULL
the	NULL
p107	NULL
is	NULL
hyperphosphorylated	NULL
and	NULL
hence	NULL
inactivated	NULL
from	NULL
G	NULL
;	NULL
»	NULL
,	NULL
through	NULL
to	NULL
G	NULL
,	NULL
-M	NULL
,	NULL
p107	NULL
may	NULL
only	NULL
have	NULL
a	NULL
major	NULL
role	NULL
in	NULL
binding	NULL
E2F	NULL
in	NULL
actively	NULL
dividing	NULL
cells	NULL
during	NULL
G14	NULL
.	NULL

In	NULL
response	NULL
to	NULL
«	NULL
-IFN	NULL
,	NULL
p130	NULL
Form	NULL
3	NULL
in	NULL
Daudi	NULL
cells	NULL
was	NULL
completely	NULL
depleted	NULL
at	NULL
a	NULL
time	NULL
when	NULL
hyperphosphorylated	NULL
pRb	NULL
was	NULL
not	NULL
.	NULL

Flow	NULL
cytometric	NULL
sorting	NULL
experiments	NULL
showed	NULL
that	NULL
p130	NULL
Form	NULL
3	NULL
was	NULL
depleted	NULL
in	NULL
all	NULL
cell	NULL
cycle	NULL
phases	NULL
after	NULL
culturing	NULL
for	NULL
40	NULL
h	NULL
with	NULL
a-IFN	NULL
,	NULL
whereas	NULL
pRb	NULL
was	NULL
only	NULL
dephosphorylated	NULL
in	NULL
G	NULL
,	NULL
.	NULL

Thus	NULL
there	NULL
is	NULL
a	NULL
clear	NULL
difference	NULL
in	NULL
the	NULL
mechanisms	NULL
regulating	NULL
these	NULL
proteins	NULL
in	NULL
different	NULL
cell	NULL
cycle	NULL
phases	NULL
.	NULL

Our	NULL
data	NULL
show	NULL
that	NULL
there	NULL
is	NULL
an	NULL
initial	NULL
response	NULL
to	NULL
«	NULL
-IFN	NULL
during	NULL
G	NULL
;	NULL
that	NULL
leads	NULL
to	NULL
the	NULL
dephosphorylation	NULL
of	NULL
pRb	NULL
and	NULL
loss	NULL
of	NULL
p130	NULL
Form	NULL
3	NULL
,	NULL
but	NULL
later	NULL
,	NULL
p130	NULL
Form	NULL
3	NULL
is	NULL
depleted	NULL
during	NULL
S+G	NULL
,	NULL
-M.	NULL
pRb	NULL
may	NULL
become	NULL
dephosphorylated	NULL
during	NULL
mitosis	NULL
(	NULL
4	NULL
)	NULL
and	NULL
,	NULL
as	NULL
certain	NULL
cdks	NULL
are	NULL
inhibited	NULL
by	NULL
«	NULL
-IFN	NULL
(	NULL
51	NULL
,	NULL
52	NULL
,	NULL
55	NULL
)	NULL
,	NULL
pRb	NULL
would	NULL
remain	NULL
hypophosphorylated	NULL
in	NULL
G	NULL
,	NULL
.	NULL

However	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
«	NULL
-IFN	NULL
on	NULL
members	NULL
of	NULL
the	NULL
cdk	NULL
family	NULL
,	NULL
such	NULL
as	NULL
edk4	NULL
and	NULL
edk6	NULL
,	NULL
which	NULL
are	NULL
active	NULL
during	NULL
early	NULL
to	NULL
mid	NULL
G	NULL
,	NULL
(	NULL
3	NULL
,	NULL
70	NULL
)	NULL
are	NULL
as	NULL
yet	NULL
unknown	NULL
.	NULL

Such	NULL
a	NULL
mechanism	NULL
does	NULL
not	NULL
explain	NULL
why	NULL
p130	NULL
Form	NULL
3	NULL
is	NULL
depleted	NULL
from	NULL
all	NULL
cell	NULL
cycle	NULL
phases	NULL
.	NULL

Our	NULL
dephosphorylation	NULL
experiments	NULL
with	NULL
A-phosphatase	NULL
would	NULL
suggest	NULL
that	NULL
p130	NULL
Form	NULL
3	NULL
could	NULL
be	NULL
converted	NULL
to	NULL
Form	NULL
1	NULL
and/or	NULL
Form	NULL
2	NULL
by	NULL
dephosphorylation	NULL
.	NULL

However	NULL
,	NULL
we	NULL
can	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
p130	NULL
Form	NULL
3	NULL
could	NULL
also	NULL
be	NULL
degraded	NULL
.	NULL

In	NULL
continuously	NULL
cycling	NULL
cells	NULL
,	NULL
less	NULL
p130	NULL
was	NULL
detected	NULL
in	NULL
samples	NULL
of	NULL
cells	NULL
sorted	NULL
into	NULL
S	NULL
and	NULL
as	NULL
compared	NULL
with	NULL
G	NULL
;	NULL
,	NULL
but	NULL
it	NULL
is	NULL
not	NULL
depleted	NULL
in	NULL
G	NULL
,	NULL
-M	NULL
,	NULL
as	NULL
reported	NULL
for	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
14	NULL
)	NULL
.	NULL

There	NULL
is	NULL
a	NULL
precedent	NULL
for	NULL
two	NULL
mechanisms	NULL
regulating	NULL
the	NULL
activity	NULL
of	NULL
one	NULL
protein	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
phosphorylated	NULL
STAT1	NULL
is	NULL
regulated	NULL
both	NULL
by	NULL
the	NULL
ubiquitin-proteasome	NULL
pathway	NULL
(	NULL
77	NULL
)	NULL
and	NULL
by	NULL
dephosphorylation	NULL
by	NULL
a	NULL
tyrosine	NULL
phosphatase	NULL
(	NULL
47	NULL
)	NULL
,	NULL
and	NULL
it	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
determine	NULL
whether	NULL
p130	NULL
is	NULL
regulated	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
.	NULL

In	NULL
order	NULL
to	NULL
determine	NULL
whether	NULL
loss	NULL
of	NULL
p130	NULL
Form	NULL
3	NULL
preceding	NULL
the	NULL
dephosphorylation	NULL
of	NULL
pRb	NULL
is	NULL
peculiar	NULL
to	NULL
cell	NULL
cycle	NULL
arrest	NULL
caused	NULL
by	NULL
a-IFN	NULL
,	NULL
we	NULL
analyzed	NULL
what	NULL
occurs	NULL
during	NULL
cell	NULL
cycle	NULL
exit	NULL
for	NULL
a	NULL
number	NULL
of	NULL
hemopoietic	NULL
cell	NULL
types	NULL
:	NULL
by	NULL
removing	NULL
IL-2	NULL
from	NULL
continuously	NULL
proliferating	NULL
primary	NULL
T-cells	NULL
,	NULL
in	NULL
Daudi	NULL
cultured	NULL
in	NULL
low	NULL
serum	NULL
,	NULL
and	NULL
in	NULL
HL60	NULL
cells	NULL
during	NULL
myeloid	NULL
differentiation	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
p130	NULL
Form	NULL
3	NULL
was	NULL
depleted	NULL
as	NULL
cells	NULL
arrested	NULL
in	NULL
G	NULL
,	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
role	NULL
for	NULL
p130	NULL
in	NULL
promoting	NULL
exit	NULL
from	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

In	NULL
HL60	NULL
cells	NULL
cultured	NULL
with	NULL
retinoic	NULL
acid	NULL
,	NULL
p130	NULL
and	NULL
pRb	NULL
were	NULL
both	NULL
dephosphorylated	NULL
at	NULL
the	NULL
same	NULL
time	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
experiments	NULL
that	NULL
suggest	NULL
that	NULL
cell	NULL
cycle	NULL
arrest	NULL
may	NULL
be	NULL
Cell	NULL
Cycle	NULL
Phosphorylation	NULL
of	NULL
the	NULL
pRb	NULL
Family	NULL
mediated	NULL
by	NULL
sequestration	NULL
of	NULL
E2F	NULL
by	NULL
pRb	NULL
and	NULL
p130	NULL
(	NULL
61	NULL
)	NULL
.	NULL

From	NULL
previous	NULL
work	NULL
,	NULL
it	NULL
was	NULL
suggested	NULL
that	NULL
a-IFN	NULL
exerts	NULL
its	NULL
antiproliferative	NULL
effects	NULL
in	NULL
part	NULL
via	NULL
the	NULL
pRb	NULL
pathway	NULL
(	NULL
5	NULL
,	NULL
7	NULL
,	NULL
50	NULL
,	NULL
51	NULL
)	NULL
.	NULL

The	NULL
cytostatic	NULL
effect	NULL
of	NULL
«	NULL
-IFN	NULL
may	NULL
occur	NULL
by	NULL
preventing	NULL
the	NULL
initial	NULL
phosphorylation	NULL
of	NULL
pRb	NULL
during	NULL
G	NULL
;	NULL
,	NULL
(	NULL
5	NULL
)	NULL
,	NULL
by	NULL
decreasing	NULL
cdk	NULL
activity	NULL
(	NULL
51	NULL
,	NULL
52	NULL
)	NULL
and	NULL
E2F	NULL
binding	NULL
(	NULL
8	NULL
,	NULL
62	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
now	NULL
show	NULL
that	NULL
a-IFN	NULL
also	NULL
causes	NULL
the	NULL
accumulation	NULL
of	NULL
p130	NULL
Form	NULL
1	NULL
and	NULL
the	NULL
depletion	NULL
of	NULL
p107	NULL
.	NULL

Finally	NULL
,	NULL
our	NULL
communoprecipitation	NULL
experiments	NULL
with	NULL
lysates	NULL
of	NULL
Daudi	NULL
cells	NULL
cultured	NULL
with	NULL
and	NULL
without	NULL
a-IFN	NULL
show	NULL
that	NULL
hypophosphorylated	NULL
forms	NULL
of	NULL
pRb	NULL
and	NULL
p107	NULL
,	NULL
and	NULL
p130	NULL
(	NULL
principally	NULL
Form	NULL
1	NULL
)	NULL
all	NULL
associate	NULL
with	NULL
E2F-4	NULL
,	NULL
whereas	NULL
E2F-1	NULL
only	NULL
coimmunoprecipitates	NULL
pRb	NULL
.	NULL

These	NULL
data	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
Ikeda	NULL
et	NULL
al	NULL
.	NULL

(	NULL
61	NULL
)	NULL
,	NULL
who	NULL
concluded	NULL
that	NULL
pRb	NULL
may	NULL
be	NULL
a	NULL
general	NULL
regulator	NULL
of	NULL
E2Fs	NULL
as	NULL
cells	NULL
exit	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
whereas	NULL
p130	NULL
is	NULL
more	NULL
specific	NULL
to	NULL
E2F-4	NULL
and	NULL
-5	NULL
.	NULL

Such	NULL
complexes	NULL
can	NULL
also	NULL
bind	NULL
an	NULL
E2F	NULL
``	NULL
*	NULL
DNA	NULL
site	NULL
in	NULL
vitro	NULL
,	NULL
but	NULL
given	NULL
that	NULL
the	NULL
subcellular	NULL
localization	NULL
of	NULL
each	NULL
complex	NULL
may	NULL
be	NULL
different	NULL
(	NULL
74	NULL
)	NULL
,	NULL
it	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
precisely	NULL
how	NULL
pRb	NULL
,	NULL
p130	NULL
,	NULL
and	NULL
p107	NULL
in	NULL
«	NULL
-IFN-arrested	NULL
cells	NULL
control	NULL
E2F	NULL
:	NULL
whether	NULL
it	NULL
is	NULL
bound	NULL
to	NULL
a	NULL
nuclear	NULL
E2F	NULL
DNA	NULL
site	NULL
or	NULL
whether	NULL
,	NULL
for	NULL
example	NULL
,	NULL
p130-E2F	NULL
binding	NULL
occurs	NULL
in	NULL
the	NULL
cytosol	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
by	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
that	NULL
the	NULL
principal	NULL
E2F	NULL
complex	NULL
in	NULL
extracts	NULL
of	NULL
primary	NULL
hemopoietic	NULL
cells	NULL
in	NULL
G	NULL
,	NULL
contains	NULL
p130-E2F-4-DP-1	NULL
(	NULL
17	NULL
,	NULL
24	NULL
,	NULL
25	NULL
)	NULL
,	NULL
which	NULL
we	NULL
have	NULL
shown	NULL
here	NULL
contains	NULL
p130	NULL
Forms	NULL
1	NULL
and	NULL
2	NULL
together	NULL
with	NULL
a	NULL
hyperphosphorylated	NULL
form	NULL
of	NULL
E2F-4	NULL
.	NULL

Thus	NULL
,	NULL
if	NULL
p130-E2F-4-DP-1	NULL
defines	NULL
cells	NULL
in	NULL
G	NULL
,	NULL
(	NULL
61	NULL
)	NULL
,	NULL
our	NULL
observations	NULL
(	NULL
Ref	NULL
.	NULL

24	NULL
and	NULL
this	NULL
paper	NULL
)	NULL
would	NULL
suggest	NULL
that	NULL
such	NULL
a	NULL
complex	NULL
contains	NULL
hyperphosphorylated	NULL
E2F-4	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
p130-E2F-4	NULL
complex	NULL
that	NULL
exists	NULL
in	NULL
Daudi	NULL
cells	NULL
arrested	NULL
by	NULL
a-IFN	NULL
contains	NULL
hypophosphorylated	NULL
forms	NULL
of	NULL
E2F-4	NULL
.	NULL

Thus	NULL
,	NULL
by	NULL
this	NULL
criterion	NULL
,	NULL
a-IFN	NULL
causes	NULL
Daudi	NULL
cells	NULL
to	NULL
arrest	NULL
in	NULL
G	NULL
,	NULL
rather	NULL
than	NULL
in	NULL
G	NULL
,	NULL
,	NULL
and	NULL
this	NULL
occurs	NULL
in	NULL
part	NULL
by	NULL
regulating	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
p130	NULL
rather	NULL
than	NULL
causing	NULL
the	NULL
hyperphosphorylation	NULL
of	NULL
E2F-4	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Helen	NULL
Wheadon	NULL
for	NULL
cultured	NULL
HL6O	NULL
cells	NULL
,	NULL
Nanah	NULL
Chavda	NULL
for	NULL
analyzing	NULL
T-cell	NULL
purity	NULL
,	NULL
and	NULL
Anthony	NULL
Best	NULL
,	NULL
Steven	NULL
Devereux	NULL
,	NULL
and	NULL
David	NULL
Linch	NULL
for	NULL
critical	NULL
comments	NULL
on	NULL
the	NULL
manu-script	NULL
.	NULL

C.	NULL
D.	NULL
W.	NULL
thanks	NULL
Dr.	NULL
A.	NULL
H.	NULL
Goldstone	NULL
for	NULL
support	NULL
.	NULL

REFERENCES	NULL
.	NULL

Goodrich	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Lee	NULL
,	NULL
W.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1155	NULL
,	NULL
48-61	NULL
.	NULL

Weinberg	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Cell	NULL
81	NULL
,	NULL
823-330	NULL
.	NULL

Tiwari	NULL
,	NULL
S.	NULL
,	NULL
Jamal	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Thomas	NULL
,	NULL
N.	NULL
S.	NULL
B	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
in	NULL
Protein	NULL
Phosphorylation	NULL
in	NULL
Cell	NULL
Growth	NULL
Regulation	NULL
(	NULL
Clemens	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
ed	NULL
)	NULL
pp	NULL
.	NULL

255-282	NULL
,	NULL
Academic	NULL
Press	NULL
,	NULL
London	NULL
4	NULL
.	NULL

Durfee	NULL
,	NULL
T.	NULL
,	NULL
Becherer	NULL
,	NULL
K.	NULL
,	NULL
Chen	NULL
,	NULL
P.-L.	NULL
,	NULL
Yeh	NULL
,	NULL
S.-H.	NULL
,	NULL
Yang	NULL
,	NULL
Y.	NULL
,	NULL
Kilburn	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
Lee	NULL
,	NULL
W.-H.	NULL
,	NULL
and	NULL
Elledge	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
555-569	NULL
.	NULL

Burke	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
Bybee	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Thomas	NULL
,	NULL
N.	NULL
S.	NULL
B	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Oncogene	NULL
7	NULL
,	NULL
788-788	NULL
.	NULL

DeCaprio	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Furukawa	NULL
,	NULL
Y.	NULL
,	NULL
Ajchenbaum	NULL
,	NULL
F.	NULL
,	NULL
Griffin	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
and	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
1796-1798	NULL
7	NULL
.	NULL

Thomas	NULL
,	NULL
N.	NULL
S.	NULL
B.	NULL
,	NULL
Burke	NULL
,	NULL
L.	NULL
C.	NULL
,	NULL
Bybee	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Linch	NULL
,	NULL
D.	NULL
C.	NULL
(	NULL
1991	NULL
)	NULL
Oncogene	NULL
6	NULL
,	NULL
317-322	NULL
8	NULL
.	NULL

Melamed	NULL
,	NULL
D.	NULL
,	NULL
Tiefenbrun	NULL
,	NULL
N.	NULL
,	NULL
Yarden	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Kimchi	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
5255-5265	NULL
9	NULL
.	NULL

Ewen	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Sluss	NULL
,	NULL
H.	NULL
K.	NULL
,	NULL
Sherr	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Matsushime	NULL
,	NULL
H.	NULL
,	NULL
Kato	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1993	NULL
)	NULL
Cell	NULL
78	NULL
,	NULL
487-497	NULL
10	NULL
.	NULL

Hannon	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
and	NULL
Beach	NULL
,	NULL
D.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
871	NULL
,	NULL
257-261	NULL
11	NULL
.	NULL

Polyak	NULL
,	NULL
K.	NULL
,	NULL
Kato	NULL
,	NULL
J.	NULL
Y.	NULL
,	NULL
Solomon	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
Sherr	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Massague	NULL
,	NULL
J.	NULL
,	NULL
Roberts	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
and	NULL
Koff	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

8	NULL
,	NULL
9-22	NULL
12	NULL
.	NULL

Hamel	NULL
,	NULL
P.	NULL
,	NULL
Phillips	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Muncaster	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Gallie	NULL
,	NULL
B.	NULL
L.	NULL
(	NULL
1998	NULL
)	NULL
FASEB	NULL
J	NULL
.	NULL

7	NULL
,	NULL
846-854	NULL
13	NULL
.	NULL

Mayol	NULL
,	NULL
X.	NULL
,	NULL
Garriga	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Grana	NULL
,	NULL
X	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Oncogene	NULL
11	NULL
,	NULL
801-808	NULL
14	NULL
.	NULL

Mayol	NULL
,	NULL
X.	NULL
,	NULL
Garriga	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Grana	NULL
,	NULL
X	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Oncogene	NULL
18	NULL
,	NULL
287-246	NULL
15	NULL
.	NULL

Hannon	NULL
,	NULL
G.	NULL
,	NULL
Demetrick	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Beach	NULL
,	NULL
D.	NULL
(	NULL
1998	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
2378-2391	NULL
16	NULL
.	NULL

Li	NULL
,	NULL
Y.	NULL
,	NULL
Graham	NULL
,	NULL
C.	NULL
,	NULL
Lacy	NULL
,	NULL
S.	NULL
,	NULL
Duncan	NULL
,	NULL
A.	NULL
M.	NULL
V.	NULL
,	NULL
and	NULL
Whyte	NULL
,	NULL
P.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
2366-2377	NULL
17	NULL
.	NULL

Vario	NULL
,	NULL
G.	NULL
,	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Ginsberg	NULL
,	NULL
D.	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
869-881	NULL
18	NULL
.	NULL

Beijesbergen	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Carlee	NULL
,	NULL
L.	NULL
,	NULL
Kerkhoven	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Bernards	NULL
,	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
1340-1858	NULL
19	NULL
.	NULL

Ewen	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
Faha	NULL
,	NULL
B.	NULL
,	NULL
Harlow	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Livingston	NULL
,	NULL
D.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
255	NULL
,	NULL
go	NULL
bo	NULL
|A	NULL
g	NULL
o	NULL
85-87	NULL
20	NULL
.	NULL

Faha	NULL
,	NULL
B.	NULL
,	NULL
Ewen	NULL
,	NULL
M.	NULL
,	NULL
Tsai	NULL
,	NULL
L.-H.	NULL
,	NULL
Livingston	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Harlow	NULL
,	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
Science	NULL
255	NULL
,	NULL
87-90	NULL
21	NULL
.	NULL

Lees	NULL
,	NULL
E.	NULL
,	NULL
Faba	NULL
,	NULL
B.	NULL
F.	NULL
,	NULL
Dulic	NULL
,	NULL
V.	NULL
,	NULL
Reed	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
and	NULL
Harlow	NULL
,	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

6	NULL
,	NULL
1874-1885	NULL
22	NULL
.	NULL

Lam	NULL
,	NULL
E.	NULL
W.-F.	NULL
,	NULL
and	NULL
LaThangue	NULL
,	NULL
N.	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

6	NULL
,	NULL
859-866	NULL
23	NULL
.	NULL

Whyte	NULL
,	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
in	NULL
Apoptosis	NULL
and	NULL
Cell	NULL
Cycle	NULL
Control	NULL
in	NULL
Cancer	NULL
(	NULL
Thomas	NULL
,	NULL
N.	NULL
S.	NULL
B.	NULL
,	NULL
ed	NULL
)	NULL
pp	NULL
.	NULL

77-92	NULL
,	NULL
Bios	NULL
Scientific	NULL
Publishers	NULL
Ltd.	NULL
,	NULL
Oxford	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43.	NULL
.	NULL

Shan	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Lee	NULL
,	NULL
W.-H.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
8166-8173	NULL
45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

Cell	NULL
Cycle	NULL
Phosphorylation	NULL
of	NULL
the	NULL
pRb	NULL
Family	NULL
Williams	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Watts	NULL
,	NULL
M.	NULL
,	NULL
Linch	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
and	NULL
Thomas	NULL
,	NULL
N.	NULL
S.	NULL
B	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Blood	NULL
90	NULL
,	NULL
194-2083	NULL
Williams	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
Linch	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
Sorensen	NULL
,	NULL
T.	NULL
S.	NULL
,	NULL
La	NULL
Thangue	NULL
,	NULL
N.	NULL
B.	NULL
,	NULL
and	NULL
Thomas	NULL
,	NULL
N.	NULL
S.	NULL
B	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Brit	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

96	NULL
,	NULL
688-696	NULL
Moberg	NULL
,	NULL
K.	NULL
,	NULL
Starz	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Lees	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
1436-1449	NULL
Smith	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
Leone	NULL
,	NULL
G.	NULL
,	NULL
DeGregori	NULL
,	NULL
J.	NULL
,	NULL
Jakoi	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Nevins	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
6965-6976	NULL
Dyson	NULL
,	NULL
N.	NULL
,	NULL
Dembski	NULL
,	NULL
M.	NULL
,	NULL
Fattaey	NULL
,	NULL
A.	NULL
,	NULL
Ngwu	NULL
,	NULL
C.	NULL
,	NULL
Ewen	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Helin	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

67	NULL
,	NULL
7641-7647	NULL
Lees	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Saito	NULL
,	NULL
M.	NULL
,	NULL
Vidal	NULL
,	NULL
M.	NULL
,	NULL
Valentine	NULL
,	NULL
M.	NULL
,	NULL
Look	NULL
,	NULL
T.	NULL
,	NULL
Harlow	NULL
,	NULL
E.	NULL
,	NULL
Dyson	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Helin	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
7818-7825	NULL
Beijesbergen	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Kerkhoven	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
Zhu	NULL
,	NULL
L.	NULL
,	NULL
Carlee	NULL
,	NULL
L.	NULL
,	NULL
Voorhoeve	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
and	NULL
Bernards	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

8	NULL
,	NULL
2680-2690	NULL
Ginsberg	NULL
,	NULL
D.	NULL
,	NULL
Vario	NULL
,	NULL
G.	NULL
,	NULL
Chittenden	NULL
,	NULL
T.	NULL
,	NULL
Xiao	NULL
,	NULL
Z.	NULL
X.	NULL
,	NULL
Xn	NULL
,	NULL
G.	NULL
,	NULL
Wydner	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
DeCaprio	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Lawrence	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
and	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
(	NULL
1994	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

8	NULL
,	NULL
2665-2679	NULL
Hijmans	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Voorhoeve	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Beijersbergen	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
va	NULL
n't	NULL
Veer	NULL
,	NULL
L.	NULL
J.	NULL
,	NULL
and	NULL
Bernards	NULL
,	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
3082-3089	NULL
Chittenden	NULL
,	NULL
T.	NULL
,	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
DeCaprio	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
,	NULL
3975-3983	NULL
Lukas	NULL
,	NULL
J.	NULL
,	NULL
Otzen	NULL
,	NULL
B.	NULL
,	NULL
Holm	NULL
,	NULL
K.	NULL
,	NULL
Bartek	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Helin	NULL
,	NULL
K.	NULL
(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
1047-1057	NULL
Johnson	NULL
,	NULL
D.	NULL
G.	NULL
,	NULL
Schwartz	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
Cress	NULL
,	NULL
W.	NULL
D.	NULL
,	NULL
and	NULL
Nevins	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
Nature	NULL
365	NULL
,	NULL
349-352	NULL
Quin	NULL
,	NULL
X.-Q	NULL
.	NULL

,	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
Kaelin	NULL
,	NULL
W.	NULL
G.	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
Adams	NULL
,	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
10918-10922	NULL
DeGregori	NULL
,	NULL
J.	NULL
,	NULL
Leone	NULL
,	NULL
G.	NULL
,	NULL
Miron	NULL
,	NULL
A.	NULL
,	NULL
Jakoi	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Nevins	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1997	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

94	NULL
,	NULL
7245-7250	NULL
Hinds	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
Mittnacht	NULL
,	NULL
S.	NULL
,	NULL
Dulic	NULL
,	NULL
V.	NULL
,	NULL
Arnold	NULL
,	NULL
A.	NULL
,	NULL
Reed	NULL
,	NULL
S.	NULL
I.	NULL
,	NULL
and	NULL
Weinberg	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
70	NULL
,	NULL
993-1006	NULL
Zhu	NULL
,	NULL
L.	NULL
,	NULL
van	NULL
den	NULL
Heuvel	NULL
,	NULL
S.	NULL
,	NULL
Helin	NULL
,	NULL
K.	NULL
,	NULL
Fattacy	NULL
,	NULL
A.	NULL
,	NULL
Ewen	NULL
,	NULL
M.	NULL
,	NULL
Livingston	NULL
,	NULL
D.	NULL
,	NULL
Dyson	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Harlow	NULL
,	NULL
E.	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

7	NULL
,	NULL
1111-1125	NULL
Claudio	NULL
,	NULL
P.	NULL
P.	NULL
,	NULL
Howard	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Baldi	NULL
,	NULL
A.	NULL
,	NULL
De-Luca	NULL
,	NULL
A.	NULL
,	NULL
Fu	NULL
,	NULL
Y.	NULL
,	NULL
Condorelli	NULL
,	NULL
G.	NULL
,	NULL
Sun	NULL
,	NULL
Y.	NULL
,	NULL
Colbuurn	NULL
,	NULL
N.	NULL
,	NULL
Calabretta	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Giordano	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

54	NULL
,	NULL
5556-5560	NULL
Zhu	NULL
,	NULL
L.	NULL
,	NULL
Enders	NULL
,	NULL
G.	NULL
,	NULL
Lees	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Beijersbergen	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Bernards	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Harlow	NULL
,	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
1904-1913	NULL
Beijersbergen	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Hijmans	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
Zhu	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Bernards	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
4080-4086	NULL
Nasmyth	NULL
,	NULL
K.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
882	NULL
,	NULL
28-29	NULL
Kowalik	NULL
,	NULL
T.	NULL
F.	NULL
,	NULL
DeGregori	NULL
,	NULL
J.	NULL
,	NULL
Schwartz	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
and	NULL
Nevins	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Virol	NULL
.	NULL

69	NULL
,	NULL
2491-2500	NULL
Wu	NULL
,	NULL
X.	NULL
,	NULL
and	NULL
Levine	NULL
,	NULL
A.	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

91	NULL
,	NULL
83602-8606	NULL
Haspel	NULL
.	NULL

R.	NULL
L.	NULL
,	NULL
Salditt-Georgieff	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
6262-6268	NULL
Haas-Kogan	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
Kogan	NULL
,	NULL
S.	NULL
C.	NULL
,	NULL
Levi	NULL
,	NULL
D.	NULL
,	NULL
Dazin	NULL
,	NULL
P.	NULL
,	NULL
T'Ang	NULL
,	NULL
A.	NULL
,	NULL
Fung	NULL
,	NULL
Y.-K.	NULL
T.	NULL
,	NULL
and	NULL
Israel	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
461-472	NULL
Baron	NULL
,	NULL
S.	NULL
,	NULL
Tyring	NULL
,	NULL
S.	NULL
K.	NULL
,	NULL
Fleischman	NULL
,	NULL
W.	NULL
R.	NULL
,	NULL
Jr.	NULL
,	NULL
Coppenhaver	NULL
,	NULL
D.	NULL
H.	NULL
,	NULL
Niesel	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Klimpel	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
Stanton	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
and	NULL
Hughes	NULL
,	NULL
T.	NULL
K.	NULL
(	NULL
1991	NULL
)	NULL
J	NULL
.	NULL

Am	NULL
.	NULL

Med	NULL
.	NULL

Assoc	NULL
.	NULL

266	NULL
,	NULL
1375-1383	NULL
50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

69	NULL
.	NULL

70	NULL
.	NULL

TL	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

23667	NULL
Resnitzky	NULL
,	NULL
D.	NULL
,	NULL
Teifenbrun	NULL
,	NULL
N.	NULL
,	NULL
Berissi	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Kimchi	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
402-406	NULL
Arany	NULL
,	NULL
I.	NULL
,	NULL
Rady	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Tyring	NULL
,	NULL
S.	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Antiviral	NULL
Res	NULL
.	NULL

28	NULL
,	NULL
131-141	NULL
Thomas	NULL
,	NULL
N.	NULL
S	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264	NULL
,	NULL
18697-13700	NULL
Yamada	NULL
,	NULL
H.	NULL
,	NULL
Ochi	NULL
,	NULL
K.	NULL
,	NULL
Nakada	NULL
,	NULL
S.	NULL
,	NULL
Nemoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Horiguchi-Yamada	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
Biochem	NULL
.	NULL

186	NULL
,	NULL
117-123	NULL
Yamada	NULL
,	NULL
H.	NULL
,	NULL
Ochi	NULL
,	NULL
K.	NULL
,	NULL
Nakada	NULL
,	NULL
S.	NULL
,	NULL
Takahara	NULL
,	NULL
S.	NULL
,	NULL
Nemoto	NULL
,	NULL
T.	NULL
,	NULL
Sekikawa	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Horiguchi-Yamada	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
Biochem	NULL
.	NULL

152	NULL
,	NULL
149-158	NULL
Zhang	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Kumar	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

200	NULL
,	NULL
522-528	NULL
Tiefbrun	NULL
,	NULL
N.	NULL
,	NULL
Melamed	NULL
,	NULL
D.	NULL
,	NULL
Levy	NULL
,	NULL
N.	NULL
,	NULL
Resnitzki	NULL
,	NULL
D.	NULL
,	NULL
Hoffman	NULL
,	NULL
I.	NULL
,	NULL
Reed	NULL
,	NULL
S.	NULL
I.	NULL
,	NULL
and	NULL
Kimchi	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

16	NULL
,	NULL
3984-3944	NULL
Kuniyasu	NULL
,	NULL
H.	NULL
,	NULL
Yasui	NULL
,	NULL
W.	NULL
,	NULL
Kitahara	NULL
,	NULL
K.	NULL
,	NULL
Naka	NULL
,	NULL
K.	NULL
,	NULL
Yokozaki	NULL
,	NULL
H.	NULL
,	NULL
Akama	NULL
,	NULL
Y.	NULL
,	NULL
Hamamoto	NULL
,	NULL
T.	NULL
,	NULL
Tahara	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Tahara	NULL
,	NULL
E.	NULL
(	NULL
1997	NULL
)	NULL
Cell	NULL
Growth	NULL
Differ	NULL
.	NULL

8	NULL
,	NULL
47-52	NULL
Subramaniam	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
and	NULL
Johnson	NULL
,	NULL
H.	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Interferon	NULL
Cytokine	NULL
Res	NULL
.	NULL

17	NULL
,	NULL
11-15	NULL
Hobeika	NULL
,	NULL
A.	NULL
C.	NULL
,	NULL
Subramaniam	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
and	NULL
Johnson	NULL
,	NULL
H.	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Oncogene	NULL
14	NULL
,	NULL
1165-1170	NULL
Sangfelt	NULL
,	NULL
O.	NULL
,	NULL
Erickson	NULL
,	NULL
S.	NULL
,	NULL
Eindhorn	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Grander	NULL
,	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
Oncogene	NULL
14	NULL
,	NULL
415-423	NULL
Ikeda	NULL
,	NULL
M.-A	NULL
.	NULL

,	NULL
Jakoi	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Nevins	NULL
,	NULL
J.	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

93	NULL
,	NULL
3215-3220	NULL
Iwase	NULL
,	NULL
S.	NULL
,	NULL
Furukawa	NULL
,	NULL
Y.	NULL
,	NULL
Kikuchi	NULL
,	NULL
J.	NULL
,	NULL
Nagai	NULL
,	NULL
M.	NULL
,	NULL
Terui	NULL
,	NULL
Y.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Yamada	NULL
,	NULL
H.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
12406-12414	NULL
Choubey	NULL
,	NULL
D.	NULL
,	NULL
Li	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Datta	NULL
,	NULL
B.	NULL
,	NULL
Gutterman	NULL
,	NULL
J.	NULL
U.	NULL
,	NULL
and	NULL
Lengyel	NULL
,	NULL
P.	NULL
(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
5668-5678	NULL
Dent	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Lillycrop	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Bybee	NULL
,	NULL
A.	NULL
,	NULL
Latchman	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
and	NULL
Thomas	NULL
,	NULL
N.	NULL
S.	NULL
B	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
,	NULL
20888-20892	NULL
Einat	NULL
,	NULL
M.	NULL
,	NULL
Resnitzky	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Kimchi	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Nature	NULL
818	NULL
,	NULL
597-600	NULL
Raveh	NULL
,	NULL
T.	NULL
,	NULL
Hovanessian	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Meurs	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
Sonenberg	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Kimchi	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
25479-25484	NULL
Zetterberg	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
in	NULL
Apoptosis	NULL
and	NULL
Cell	NULL
Cycle	NULL
Control	NULL
in	NULL
Cancer	NULL
(	NULL
Thomas	NULL
,	NULL
N.	NULL
S.	NULL
B.	NULL
,	NULL
ed	NULL
.	NULL
)	NULL

pp	NULL
.	NULL

17-36	NULL
,	NULL
Bios	NULL
Scientific	NULL
Publishers	NULL
Ltd.	NULL
,	NULL
Oxford	NULL
Devalia	NULL
,	NULL
V.	NULL
,	NULL
Thomas	NULL
,	NULL
N.	NULL
S.	NULL
B.	NULL
,	NULL
Roberts	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
Jones	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
and	NULL
Linch	NULL
,	NULL
D.	NULL
C.	NULL
(	NULL
1992	NULL
)	NULL
Blood	NULL
80	NULL
,	NULL
68-76	NULL
Darzynkiewicz	NULL
,	NULL
Z.	NULL
,	NULL
Crissman	NULL
,	NULL
H.	NULL
,	NULL
Traganos	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
SteinKamp	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

118	NULL
,	NULL
465-474	NULL
Thomas	NULL
,	NULL
N.	NULL
S.	NULL
B	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
in	NULL
Textbook	NULL
of	NULL
Malignant	NULL
Haematology	NULL
(	NULL
Degos	NULL
,	NULL
L.	NULL
,	NULL
Linch	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Lowenberg	NULL
,	NULL
B.	NULL
,	NULL
eds	NULL
)	NULL
pp	NULL
.	NULL

183-152	NULL
,	NULL
Martin	NULL
Dunitz	NULL
Publishers	NULL
,	NULL
London	NULL
Dalton	NULL
,	NULL
S.	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
1797-1804	NULL
Welch	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
and	NULL
Wang	NULL
,	NULL
J.	NULL
Y.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Nafl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

89	NULL
,	NULL
3093-3097	NULL
Tommasi	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Pfeifer	NULL
,	NULL
G.	NULL
P.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
6901-6913	NULL
Verona	NULL
,	NULL
R.	NULL
,	NULL
Moberg	NULL
,	NULL
K.	NULL
,	NULL
Estes	NULL
,	NULL
S.	NULL
,	NULL
Starz	NULL
,	NULL
M.	NULL
,	NULL
Vernon	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
and	NULL
Lees	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

17	NULL
,	NULL
7268-7282	NULL
Taya	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

22	NULL
,	NULL
14-17	NULL
Shirodkar	NULL
,	NULL
S.	NULL
,	NULL
Ewen	NULL
,	NULL
M.	NULL
,	NULL
DeCaprio	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Morgan	NULL
,	NULL
J.	NULL
,	NULL
Livingston	NULL
,	NULL
D.	NULL
M.	NULL
,	NULL
and	NULL
Chittenden	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
68	NULL
,	NULL
157-166	NULL
Kim	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T.	NULL
(	NULL
1996	NULL
)	NULL
Science	NULL
278	NULL
,	NULL
1717-1719	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL
p130	NULL
,	NULL
p107	NULL
,	NULL
and	NULL
pRb	NULL
Are	NULL
Differentially	NULL
Regulated	NULL
in	NULL
Proliferating	NULL
Cells	NULL
and	NULL
during	NULL
Cell	NULL
Cycle	NULL
Arrest	NULL
by	NULL
O-Interferon	NULL
Nicholas	NULL
S.	NULL
B.	NULL
Thomas	NULL
,	NULL
Arnold	NULL
R.	NULL
Pizzey	NULL
,	NULL
Sanjay	NULL
Tiwari	NULL
,	NULL
Catherine	NULL
D.	NULL
Williams	NULL
and	NULL
Jiewu	NULL
Yang	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1998	NULL
,	NULL
273:23659-23667.	NULL
doi	NULL
:	NULL
10.1074/jb0.273.37.23659	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/273/37/23659	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
73	NULL
references	NULL
,	NULL
39	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
.	NULL

full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

